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INTRODUCTION 
 “Acute pancreatitis includes  a wide spectrum of disease, from one 
with mild self limiting symptoms to fulminant process with multiorgan 
failure and high mortality”.Given the wide spectrum of disease seen, the 
care of the patients with pancreatitis must be highly individualized . 
The “early diagnosis and precise scoring of disease severity” are 
important goals in the initial evaluation and the management of 
pancreatitis. Pancreatitis not only must be differentiated from a myriad of 
other potential diagnoses, but patients also must be stratified to identify 
those with severe disease and to guide appropriate therapy. 
Of the several scoring systems used, commonly used Ranson and 
Apache II scoring systems guide in the prediction of the severity of the 
disease, but the efficacy between these two scoring systems remains a 
debate and hence the need for the study. 
  
Aims and Objectives 
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OBJECTIVES 
“To compare the efficacy of Ranson scoring with Apache II 
scoring system in predicting the severity of acute pancreatitis”. 
  
Review Of Literature 
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REVIEW OF LITERATURE 
History: 
 “An early description of acute pancreatitis was given by Ambrose 
Pare in 1579. However, the importance of pancreas and the severity of its 
inflammatory disorders were not appreciated until its function as a 
digestive organ was delineated in the mid seventeenth century. In 1886, 
Nicholas Senn suggested that operative treatment for acute pancreatitis 
might be indicated in pancreatic gangrene or abscess formation”. 
“In 1901, Opie described gall stones as a cause of pancreatitis by 
documenting and impacted gall stone in the ampulla of Vater during 
autopsy  of  a  patient  who  died  of  pancreatitis.  The  first  plausible  
explanations of the pathogenesis of acute pancreatitis were hypothesized 
by Halsted, Osler, and Opie, contemporaries at Johns Hopkins hospital”. 
In 1925, Sir Berkeley Moynihan declared that “acute pancreatitis is 
the  most  terrible  of  all  the  calamities  occurring  in  conjunction  with  the  
abdominal viscera,” which still holds true today. Acute pancreatitis has 
widely variable clinical and systemic manifestations spanning the 
spectrum from a mild, self-limiting episode of epigastric pain to severe, 
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life- threatening, multiorgan failure including sepsis, renal failure, acute 
respiratory distress syndrome, and death. 
Improved outcomes are clearly linked to advancements in 
supportive care Currently, the only effective therapeutic interventions 
address the complications of acute pancreatitis, most commonly biliary 
sepsis, pancreatic necrosis, pseudocysts, infection, and sepsis; the latter 
account for mortality rates in excess of 50% to 80%. The advent and 
integration of minimally invasive surgery, including advanced 
endoscopic, radiologic and interventional techniques, are changing the 
management of complicated, acute pancreatitis. Incorporation of these 
modalities has brought into question the use and timing of operative 
management for pancreatic necrosis, pseudocysts, and gallstones. 
DEFINITIONS: 
Acute pancreatitis is an acute inflammatory process of the pancreas with 
varying involvement of other regional tissues or remote organ systems1. 
“Pancreatitis is classified as acute unless there are computed tomography 
(CT) or endosopic retrograde cholangiopancreatography (ERCP) findings 
of chronic pancreatitis. Then pancreatitis is classified as chronic 
pancreatitis, and any episode of “acute pancreatitis” is considered an 
exacerbation of inflammation superimposed on chronic pancreatitis”. 
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Mild acute pancreatitis consists of no organ dysfunction and an 
uneventful recovery2. 
Severe pancreatitis manifests as organ failure and/or local complications 
such as necrosis, abscess, and pseudocyst3(Table 1). 
Other acceptable markers of severe pancreatitis are 3 or more of 
the 11 Ranson criteria for nongallstone pancreatitis (Table 2) and the 
second Acute Physiology and chronic Health Evaluation (APACHE II) 
score higher than 8”. 
Dynamic contrast – enhanced CT scans can distinguish interstitial 
from necrotizing Pancreatitis. 
“An acute fluid collection is fluid located in or near the pancreas 
that lacks a definite wall and that occurs early in the course- of acute 
pancreatitis” 
“A pseudocyst is a fluid collection that persists for 4 to 6 weeks 
and becomes encapsulated by a wall of fibrous or granulation tissue”. 
“A pancreatic abscess is a circumscribed intra- abdominal 
collection of pus after an episode of acute pancreatitis or pancreatic 
trauma. It usually develops close to the pancreas and contains little or no 
pancreatic necrosis”. 
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“Pancreatic necrosis is a diffuse or focal area (s) of nonviable 
pancreatic parenchyma, which is typically associated with peripancreatic 
fat necrosis”. 
Table 1 : Atlanta Criteria for Severe Acute Pancreatitis 
 
NATURAL HISTORY: 
 “About 80% of attacks are mild, and normal pancreatic 
morphology and function are the rule after recovery if no further attacks 
occur. About 20% are severe, and they are commonly accompanied by 
necrosis of the pancreas and or organ failure”. About one fourth to one 
third of patients with severe pancreatitis die from their disease, for a total 
mortality rate of 2% to 10%11 . 
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“There are two time peaks for morality. Most studies in the United 
States and Europe show that about one half the deaths occur within the 
first week or two, usually from multiorgan failure. 11-14 Death can be very 
rapid. About one fourth of all deaths in Scotland occur Within 24 hours of 
admission, and one third 48 hours15 After the second week of illness 
patients succumb to pancreatic infection associated with multiorgan 
failure”. 
 “Some studies in Europe report a very high rate of late mortality 
from infection.Patients who are older and have comorbid illnesses have a 
substantially higher rate of mortality than younger healthier patients16 . In 
those who survive the illness, severe pancreatic necrosis can scar the 
pancreas, resulting in a structure of the main pancreatic duct with 
subsequent obstructive chronic pancreatitis and permanent diabetes and 
malabsorption17”      
 “Obese patients with pancreatitis have a higher incidence of local 
complications18,respiratory failure19, severe acute pancreatitis20 and death 
from sterile necrosis21 than nonobese patients”. 
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PATHOLOGY: 
  “Most causes of acute pancreatitis (i.e., alcohol, gallstones, and 
drugs) involve initial injury to peripheral acinar cells, fat necrosis, and 
autodigestion. The peripheral cells are distant from the arterial supply of 
pancreatic lobules, and some parenchymal damage likely is due to 
abnormalities of the microcirculation”. In comparison, infections agents 
are directly toxic to acinar cells and cause generalized acinar cell necrosis 
associated with an acute inflammatory infiltrate21. In contrast, the earliest 
lesion produced by pancreatitis due to hypotension is ductal necrosis22. 
 “Pathologically, there are two main types of pancreatitis interstitial 
and necrotizing. Interstitial pancreatitis (also called edematous 
pancreatitis) is characterized by interstitial edema associated with 
inflammatory cells within the parenchyma. Although parenchymal 
necrosis may occur, it is microscopic. Small foci of fat necrosis 
characteristically punctuate the surface of the gland. This type of finding 
is usually associated with a mild clinical course”. 
 “The major features of necrotizing pancreatitis are macroscopic 
focal or diffuse necrosis of the pancreatic parenchyma, large areas of fat 
necrosis, and, occasionally, hemorrhage on the surface on the pancreas 
and in peripancreatic tissue. Granulocytes and macrophages demarcate 
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areas of necrosis, which may involve acinar cells, islet cells, and the 
pancreatic ductal system. Pancreatic necrosis is present mostly in the 
periphery of the lobules, but it may progress to involve most of the gland. 
Severe interstitial fat necrosis involves small veins and venules, which 
may be infiltrated by granulocytes, leading to thrombosis, necrosis, and 
rupture. Arterial thrombosis is observed infrequently”. 
PATHOGENESIS: 
 “The initial step in the pathogenesis of acute pancreatitis is 
conversion of trypsinogen to trypsin within acinar cells in sufficient 
quantities to overwhelm normal mechanisms to remove active trypsin8. 
Trypsin, in turn, catalyzes conversion of pro enzymes, including 
trypsinogen and inactive precursors of elastase, phospholipase and 
carboxypeptidase, to active enzymes9. Normally, small amounts of 
trypsingogen are spontaneously activated within the pancreas, but 
intrapancreatic mechanisms quickly remove activated trypsin10. 
Pancreatic secretory trypsin inhibitor (PSTI, now called SPINKI) binds 
and inactivates about 20% of the trypsin activity11.”  
“Colocalization of pancreatic enzymes, followed by acinar cell 
injury, is an attractive hypothesis for the pathogenesis of acute 
pancreatitis, but the relevance of colocalization to the pathogenesis of 
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acute pancreatitis is unclear12. Activation of trypsinogen occurs before 
biochemical or morphologic injury to acinar cells, in association with 
colocalization of lysosomal enzymes, such as cathepsin B, and digestive 
enzymes, including trypsinogen with unstable vacuoles24. Thus, complete 
inhibition of cathepsin B either may prevent or may be a treatment for 
acute pancreatitis25. However, enzyme colocalization may occur without 
inducing significant acinar cell injury”.  
“Mutations in the cystic fibrosis transmembrane conductance 
regulator (CFTR) gene (CTFR) have also been implicated in panceatitis. 
CFTR anion channel allows for secretion of chloride and bicarbonate into 
the ducts and, thus, flushing of the liberated enzymes and proenzymes 
into the duodenum. More than 1200 mutations have been described for 
the CFTR gene”. 
 “A third genetic abnormality associated with pancreatitis is a 
mutation of the SPINK 1 gene. As noted previously, SPINK 1 protects 
the pancreatic acinar cell by inhibiting prematurely activated trypsin. 
Mutations  of  the  SPINKI  gene  presumably  limit  the  activity  of  the  
protein, but the exact mechanism is unclear”. 
“The pathogenesis of gallstone- related pancreatitis is unknown. 
Factors that may initiate gallstone pancreatitis include reflux of bile into 
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the pancreatic duct38,39 and obstruction of the pancreatic duct at the 
ampulla secondary to stone(s) or to edema resulting from the passage of a 
stone40. Reflux of bile into the pancreatic duct could occur when the distal 
common  bile  and  pancreatic  ducts  from  a  common  channel  and  a  
gallstone becomes impacted in the duodenal papilla”. Alternatively, bile 
could reflux into the pancreatic duct from the duodenum through an 
incompetent sphincter of Oddi inured by recent passage of a gallstone15.” 
“Experimentally, reflux of bile, particularly if infected or mixed 
with pancreatic enzymes, causes pancreatic injury. Mixtures of bile and 
pancreatic enzymes raise the permeability of the main pancreatic duct, 
which is associated with local parenchymal inflammation41. The common 
channel theory is somewhat problematic, however, because pancreatic 
duct pressure is invariably higher than common bile duct pressure, 
making bile reflux unlikely. Reflux of bile from the duodenum is also an 
unlikely pathogenetic factor, because pancreatitis does not occur in 
conditions with easily demonstrable reflux, such as after surgical 
sphincteroplasty or endoscopic sphincterotomy16.” 
“A popular opinion for the mechanism of gallstone pancreatitis is 
that an impacted gallstone in the distal common bile duct obstructs the 
pancreatic duct, which increases pancreatic pressure, thereby damaging 
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ductal and acinar cells. Experiments in the opossum support this theory: 
Ligation of the pancreatic duct causes severe necrotizing pancreatitis38, 
and decompression of the duct within 3 days prevents progression to 
acinar cell necrosis and severe inflammation40.” 
PATHOPHYSIOLOGY: 
 “The pathophysiology of acute pancreatitis starts with local acinar 
injury, which if unchecked leads to local inflammatory complications, a 
systemic response, and sepsis. Pathophysiologic mechanisms include 
microcirculatory injury, leukocyte chemoattraction, release of proint 
amatory and anti- inflammatory cytokines, oxidative stress, leakage of 
pancreatic fluid into the region of the pancreas, and bacterial 
translocation to the pancreas and systemic circulation”. 
“The release of pancreatic enzymes damages the vascular 
endothelium, the interstitium, and acinar cells42. Acinar injury leads to 
expression of endothelial adhesion molecules  (e.g., vascular cell 
adhesion molecule- I [VCAM –I]) which further propagates the 
inflammatory response45. Microcirculatory changes, including 
vasoconstriction, capillary stasis, decreased oxygen saturation. And 
progressive ischemia, occur early in experimental acute pancreatitis. 
These abnormalities enhance vascular permeability and lead to edema of 
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the gland (edematous or interstitial pancreatitis). Vascular injury could 
cause local microcirculatory failure and amplification of the pancreatic 
injury. It is uncertain whether ischemia- reperfusion injury occurs in the 
pancreas44. Reperfusion of damaged pancreatic tissue could lead to the 
release of free radicals and inflammatory cytokines into the circulation, 
which could cause further injury. In early stages of animal and human 
pancreatitis, activation of complement play significant role in the 
recruitment of macrophagpes and polymorphonuclear leukocytes46,48. 
Active granulocytes and macrophages release proinflammatory cytokines 
in response to transcription factors such as nuclear factor kappa B 
(NFICB). Proinflammatory cytokines incude tumor necrosis factor 
(TNF), interleukins IL – 1, IL-6, and IL-8, and platelet – activating factor 
(PAF). Activation of proinflammatory cytokines is frequently followed 
by anti- inflammatory cytokines (IL-2, IL-10, IL-11), which attempt to 
down regulate inflammtion45. Other mediators of inflammation are 
arachidonic acid metabolites (prostaglandins, leukotrienes, PAF), nitric 
oxide, proteolytic and lipolytic enzymes, and reactive oxygen metabolites 
that overwhelm scavenging by endogenous antioxidant systems. These 
substances also act on the pancreatic microcirculation to increase vascular 
permeability, which induces thrombosis and hemorrhage and leads to 
pancreatic necrosis. A 1996 study suggests that gene polymorphisms that 
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affect acinar cell glutathione concentrations may lead to increased 
oxidant stree and more severe pancreatitis”. 
 “Meanwhile, ischemia and severe inflammation of the gland can 
engender disruption of the main and secondary pancreatic ducts, leading 
to local fluid accumulations within and surrounding the pancreas that can 
eventuate into pseudocysts49.” 
“Some patients with severe pancreatic damage have systemic 
complication, including fever, acute respiratory distress syndrome 
(ARDS), pleural effusions, renal failure, shock, myocardial depression, 
and numerous metabolic complications. The systemic inflammatory 
response syndrome (SIRS) is common and is proably mediated by 
activated pancreatic enzymes (phospholipse, elastase, trypsin, etc.) and 
cytokines such as TNF and PAF released into the portal circulation from 
the inflamed pancreas52.Cytokines reaching the liver activate hepatic 
Kupffer cells, which in turn induce hepatic expression and secretion of 
cytokines into the systemic circulation. These acute- phase protein 
synthesis (C- reactive protein (CRP), IL- 6) and may lead to the systemic 
inflammatory response syndrome and damage to the kidneys, lungs, and 
other organs, resulting in multiorgan dysfunction and failure53.” 
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 “ARDS, which is secondary to microvascular thrombosis ,may be 
induced by active phospholipase A (lecithinase), which digests lecithin, a 
major component of lung surfactant. Acute renal failure has been 
explained on the basis of hypovolemia and hypotension. Myocardial 
depression and shock are likely secondary to vasoactive peptides and a 
myocardial depressant factor. Metabolic complications include 
hypocalcemia, hyperlipidemia, hyperglycemia with or without 
ketoacidosis, and hypoglycemia. The pathogenesis of hypocalcemia is 
multifactorial and include hypoalbuminemia (the most important cause), 
hypomagnesemia, calcium- soap formation, hormonal imbalances (e.g., 
parathyroid hormone, calcitonin, and glucagon), binding of calcium by 
free fatty acid- albumin complexes, intracellular translocation of calcium, 
and systemic exposure to endotoxin54.” 
 “Pancreatic infection (infected necrosis and abscess) can occur 
from the hematogenous route or from translocation of bacteria from the 
colon into the lymphatics. Under normal circumstances, bacterial 
translocation does not occur because there are complex immunologic and 
morphologic barriers. During acute pancreatitis, however, these barriers 
break down, possibly resulting in local and systemic infection55. 
Penetration of the gut barrier by enteric bacteria is probably due to gut 
ischemia secondary to hypovolemia and pancreatitis- induced 
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arteriovenous shunting in the gut. Indeed, in canine experimental 
pancreatitis, enclosing the colon in impermeable bags prevents 
translocation of bacteria from the colon to the pancreas58.” 
ETIOLOGY: 
“Many conditions predispose to acute pancreatitis to varying 
extents, as listed in Table -2. This list will undoubtedly continue to grow, 
and the number of cases diagnosed as “idiopathic” will fall as our 
understanding of the disease improves. Gallstones and chronic alcohol 
abuse account for 70% of cases of acute pancreatitis”.  
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Table 2: conditions predisposing to acute pancreatitis: 
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OBSTRUCTIVE CAUSES: 
Gallstones: 
 “The most common obstructive process leading to pancreatitis is 
gallstones, which cause approximately 40% of cases of acute 
pancreatitis59. Cholecystectomy with clearing of the common bile duct of 
stones prevents recurrence, confirming the cause and effect relationship60. 
However, only 3% to 7% of patients with gallstones experience 
pancreatitis60.  The  risk  of  development  of  acute  pancreatitis  due  to  
gallstones is relatively greater in men (relative risk, 14 to 35) than in 
women (relative risk, 12 to 25)60. However, more women experience 
gallstone pancreatitis because gallstones are more common in women60. 
Acute pancreatitis occurs more frequently when stones are les than 5mm 
in diameter (odds ratio, 4 to 5)61. Small stones are more likely than large 
stones to pass through the cystic duct and cause ampullary obstruction”. 
Biliary sludge/microlithiasis: 
 “Biliary sludge is a viscous suspension in gallbladder bile that may 
contain small stones, or microlithiasis (<3 mm in diameter)62. Because 
small stones can hide in biliary sludge, the two are commonly referred 
together as biliary slude/microlithiasis. Biliary sludge is asymptomatic in 
most patients. It is usually composed of cholesterol monohydrate crystals 
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or calcium bilirubinate granules63. On ultrasound it is a mobile, low 
amplitude echo that does not produce a shadow and that layers in the 
most dependent part of the gallbaladder”. 
 “Sludge occurs with functional or mechanical bile stasis. Common 
associations are a prolonged fast, total parenteral nutrition, and distal bile 
duct obstruction. In addition, the cephalosporin antibiotic ceftriaxone can 
complex  with  bile  to  form  a  sludge  within  the  biliary  system  when  its  
solubility in bile is exceeded; rarely, this sludge causes stone64 that 
disappear after the patient stops taking the drug. Commonly, biliary 
sludge occurs in acute pancreatitis with no abvious cause. However, the 
association between biliary sludge and acute pancreatitis is unproved. 
There is no prospective, randomized study documenting that removing 
sludge or microcrystals via cholecystectomy prevents further attacks of 
pancreatitis”. 
TUMOURS: 
 “Presumably by obstructing the pancreatic duct, tumors can cause 
recurrent. Acute pancreatitis, especially in individuals older than 40 
years.  The  most  common  tumors  that  manifest  in  this  manner  are  
intraductal mucinous tumors of the pancreas68. Adenocarcinoma can 
manifest as acute pancreatitis in a small percentage of patients69. 
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Metastases from other primary tumors (lung, breast) to the pancreas have 
also caused pancreatitis70. Large adenomas of the major papilla can 
likewise occasionally cause obstructive pancreatitis. Other obstructive 
conditions that are rarely associated with acute pancreatitis are 
choledochoceles, duodental diverticula, annular pancreas, and space 
occupying parasites that obstruct the pancreaticobiliary system, such as 
Ascaris and Clonorchis”. 
ALCOHOL TOXINS AND DRUGS 
Ethyl alcohol 
“Alcohol causes at least 30% of cases of acute pancreatitis59 .The 
mechanism of alcohol-induced pancreatitis is unclear. Hypotheses include 
relaxation of the sphincter of Oddi with reflux of duodenal content into 
the pancreatic duct, spasm of the sphincter of Oddi with reflux of bile into 
the pancreatic duct, greater permeability of the pancreatic duct, and 
sudden release of large amounts of enzymes that are inappropriately 
activated. Alcohol increases synthesis of digestive and lysosomal 
enzymes by pancreatic acinar cells. Other hypotheses are that longterm 
ingestion of alcohol leads to higher protein concentration in pancreatic 
juice, which obstructs small ductules, and that ethanol or one of its 
metabolites directly injures acinar cells (the toxicmetabolic hypothesis). 
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The fact that pancreatitis develops in only a small percentage of chronic 
alcoholics suggests underlying genetic susceptibility. To date, no strong 
genetic connection has been found to explain this occurrence”. 
Other toxins: 
 “Methyl alcohol, organophosphorus insecticides, and the venom of 
the Trinidad scorpion have all been reported to induce pancreatitis. The 
mechanism of the latter two is believed to be hyperstimulation of the 
pancreas. Smoking raises the risk of alcoholic and idiopathic, but not 
gallstone, pancreatitis”. 
Drugs: 
“Medications are an uncommon but important cause of acute 
pancreatitis. More than 85 drugs have been implicated, mostly from case 
and anecdotal reports. Most case reports are unconvincing. 
Documentation of drug induced pancreatitis is most secure if (1) other 
likely causes of pancreatitis are adequately ruled out, (2) there is in 
appropriate interval between initiation of the drug therapy and induction 
of pancreatitis (4-8weeks for most drugs), (3) there is a clear mechanism 
of drug induced pancreatitis (e.g., the drug causes hypertiglyceridemia, 
which causes pancreatitis), and, most importantly, (4)  pancreatitis is 
reproduced on rechallenge with the drug. Table-3 lists drugs that have 
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caused pancreatitis on rechallenge. The reader should notice that classes 
of drugs are not used but, rather, the specific drugs. Because drug induced 
pancreatitis is very uncommon and most cases are idiosyncratic, it would 
not be correct to state that a whole class of drugs (e.g., angiotensin- 
converting enzyme inhibitors) are potential offenders, if only one of the 
class (perindopril) has been documented to cause the disease”. 
“There are several potential pathogenetic mechanisms of drug- 
induced pancreatitis. The most common is a hypersensitivity reaction. 
This tends to occur 4 to 8 weeks after the drug is started and is not a dose 
related phenomenon. On rechallenge with the drug, pancreatitis recurs 
within hours to days. Examples of drugs that operate through this 
mechanism are 6 mercaptopurine/ azathioprine, aminosalicylates, 
metronidazole, and tetracycline.    “The second mechanism is the 
presumed accumulation of a toxic metabolite that may cause 
pancreatitis”. “Typically, drugs like these cause pancreatitis after several 
months of  use.  Examples of  drugs in this  category are valproic acid and 
didanosine.Drugs that induce hyper triglyceridemia (thiazides, 
isotretinoin, tamoxifen, etc) are also in this category. Finally, a very few 
drugs may have intrinsic toxicity wherein an overdose can cause 
pancreatitis (erythromycin, acetaminophen). There is no documentation 
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that drugs can cause pancreatitis after years of use. Drug- induced 
pancreatitis tends to be mild and self- limited”. 
Table 3: Drugs that Cause Pancreatitis after Rechallenge 
Alpha- methyldopa 
5- Aminosalicylate (mesalamine) 
Azathioprine 
Cimetidine 
Cytosine arabinoside 
Dexamethasone 
Ethinylestradiol/lynestrenol 
Furosemide 
Isoniazid 
6- Iercaptopurine 
Metronidazole 
Norethindrone/mestranol 
Pentamidine 
Perindopril 
Pravastatin 
Procainamide 
Sulfamethizole 
Sulfasalazine 
Selindac 
Tetracycline 
Trimethoprim/sulfamethoxazole 
Valproic acid 
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METABOLIC CAUSES: 
Hypertriglyceridemia: 
 “Hypertriglyceridemia is perhaps the third most common 
identifiable, noniatrogenic cause of pancreatitis, after gallstones and 
alcoholism. Serum triglyceride concentrations exceeding 1000mg/dL 
(11mmol/L) may precipitate attacks of acute pancreatitis. Patients may 
have lactescent (milky) serum owing to increased concentrations of very-
low- densitiy lipoprotein( VLDL), and at higher VLDL levels, owing to 
hyperchylomicronemia. The pathogenesis of hypertriglyceridemic 
pancreatitis is unclear, but the release of free fatty acids may damage 
pancreatic acinar cells or capillary endothelium”. 
 “Most adults with hyperchylomicronemia have a mild form of 
genetically inherited type I or type V hyperlipoproteinemia and an 
additional condition known to raise serum lipids (e.g., alcohol abuse, 
obesity, insulin resistance, diabetes mellitus, hypothyroidism, pregnancy, 
estrogen / tamoxifen therapy, gluocorticoid excess, nephritic syndrome, 
or beta- blocker therapy). Typically, three types of patients experience 
hypertriglyceridemia induced pancreatitis. The first is a patient with 
poorly controlled diabetes and a history of hypertriglyceridemia; 
administration of insulin rapidly lowers serum triglyceride levels.The 
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second is an alcoholic patient who is found to have hypertriglyceridemia 
on hospital admission. The third (15% to 20%) is a nondiabetic, 
nonalcoholic, non obese person who has drug or diet- induced 
hypertriglyceridemia. Drug induced disease is more likely to occur if 
there is underlying hypertriglyceridemia.Most people who abuse alcohol 
have moderate, but transient, elevations of serum triglycerides. This 
condition is likely an epiphenomenon and not the cause of 
pancreatitis,because alcohol raises serum triglyceride concentrations in a 
“dose-dependent” manner. For example, the prevalence of serum 
triglyceride concentrations higher than 227mg/dL (2.5mmol/L were 10%, 
14% and 2091> in persons who had 3 to 5,6to 8 and 9 or more alcoholic 
drinks per day, respectively. Alcoholic patients with severe 
hyperlipidemia often have a coexisting primary genetic disorder of 
lipoprotein metabolism”. 
Hypercalcaemia: 
 “Hypercalcemia of any cause is rarely associated with acute 
pancreatitis. Proposed mechanisms include deposition of calcium in the 
pancreatic duct and calcium activation of trypsinogen within the 
pancreatic parenchyma. The low incidence of pancreatitis in chronic 
hypercalcemia suggests that other factors (e.g., acute elevations of serum 
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calcium) are responsible for pancreatitis, particularly because sudden 
infusion of high levels of calcium into rats leads to conversion of 
trypsinogen to trypsin, hyperamylasemia, and dose- dependent 
morphologic changes of acute pancreatitis such as edema and acinar cell 
necrosis”. 
 “Hypercalcemia due to hyperparathyroidism is a proposed cause 
of pancreatitis.However, primary hyperparathyroidism causes less than 
0.5% of all cases of acute pancreatitis, and the incidence of acute 
pancreatitis in hyperparathyroidism varies from 0.2% to 1.5%94. Rarely, 
pancreatitis occurs with other causes of hypercalcemia, including 
metastatic. Bone disease, total paranteral nutrition, sarcoidosis, vitamin D 
toxicity and peri-operative infusions of calcium in high doses during 
cardiopulmonary bypass surgery”. 
INFECTIONS: 
 “Many infectious agents may cause acute pancreatitis but often, 
reports do not meet standards for the diagnosis of pancreatitis or the 
infection. If modern criteria for diagnosis of pancreatitis and infection are 
used, pancreatitis can be associated ‘with infectious agents with varying 
degrees of certainty. “Definite pancreatitis” exists if there is surgical, 
autopsy, or radiologic evidence; “probable pancreatitis” exists if there are 
27 
 
biochemical evidence (more than three times elevation of serum lipase or 
amylase) and characteristic symptoms; and “possible pancreatitis” exists 
if there is only asymptomatic biochemical evidence. The definitive 
criterion for an infection causing pancreatitis is finding the organism in 
the pancreas or pancreatic duct through stain or culture. Probable criteria 
are culture of the organism from pancreatic juice or blood or serologic 
evidence combined with a characteristic clinical or epidemiologic setting. 
The criterion of a possible infection is culture of the organism from other 
body sites or serologic evidence of infection”. 
“These criteria show that definite pancreatitis has been associated 
with viruses (mumps, coxsackievirus, hepatitis B, cytomegalovirus, 
varicella- zoster, herpes simplex, Epstein- Barr, hepatitis A, and non- A, 
non- B hepatitis); the vaccine that contains attenuated measles, mumps, 
and rubella; bacteria (Mycoplasma, Legionella, Leptospira, Salmonella, 
Tuberculosis and Brucellosis); fungi (Aspergillus and Candida Albicans); 
and parasites (Toxoplasma, Cryptosporidium, Ascaris, Clonorchis 
Sinensis). Clonorchis sinensis and Ascaris cause pancreatitis by blocking 
the main pancreatic duct. In patients with acquired immunodeficiency, 
syndrome (AIDS), infectious agents that cause acute pancreatitis include 
cytomegalovirus Candida, Cryptococcus neoformans, Toxoplasma 
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gondii, and possibly opportunistic organisms such as Mycobacterium 
aviumcomplex75.” 
VASCULAR  DISEASE: 
 “Rarely, pancreatic ischemia causes pancreatitis. In most cases it 
is mild, but fatal necrotizing pancreatitis may occur. Ischemia may result 
from vasculitis (systemic lupus erythematosus, polyateritis nodosa), 
atheromatous embolization of cholesterol plaques from the aorta to the 
pancreas after transabdominal angiography, intraoperative hypotension, 
hemorrhagic shock, ergotamine overdose, and transcatheter arterial 
embolization for hepatocellular carcinoma. Acute pancreatitis has 
occurred in long distance runners, perhaps on an ischemic basis. Also, 
ischemia is one possible explanation for pancreatitis after 
cardiopulmonary bypass”. 
TRAUMA: 
 “Either penetrating trauma (gunshot or stab wounds) or blunt 
trauma can damage the pancreas, although these injuries are uncommon 
causes of pancreatitis. In most cases, there is also injury to adjacent 
viscera. Laparotomy is essential in all cases of penetrating trauma to 
assess and treat all intra- abdominal injuries, including those to the 
pancreas.Blunt trauma results from compression of the pancreas by the 
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spine, such as in an automobile accident. In blunt trauma, it is important 
to determine preoperatively whether there is injury to the pancreas, 
because the severity of pancreatic injury determines whether the pancreas 
must be included in the surgical plan.Even in the absence of serious 
injury to adjacent organs, surgery may be necessary to treat a pancreatic 
ductal injury.This injury cause acute duct rupture and pancreatic 
ascites.Serum amylase activity maybe increased in abdominal trauma 
whether or not the pancreas has been injured”. 
Endoscopic Retrograde CholangioPancreaticography: 
 “Asymptomatic hyperamylasemia occurs after 35% to 70% of 
ECRPs. Acute pancreatitis Occurs after 5% of diagnostic ERCPs, after 
7% of therapeutic ERCPs and in up to 25% of patients with suspected 
sphincter or Oddi dysfunction or prior history of Post ERCP 
pancreatitis.Both patient characteristics and technique- related factors put 
patients at risk for ERCP pancreatitis.Difficult cannulation, biliary 
balloon dilation, pancreatic sphincterotomy, use of more than one 
pancreatic contract injection, and suspected sphincter of Oddi dysfunction 
likewise increase the risk two to four- fold”. 
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SURGERY: 
 “Postoperative pancreatitis can occur after abdominal or thoracic 
surgery. Pancreatitis occurs after 6% of liver transplantations  and after 
0.4% to 7.6% of cardiopulmonary bypass operations.Significant risks for 
pancreatitis after cardiopulmonary bypass are preoperative renal 
insufficiency, postoperative hypotension, and perioperative 
administration of calcium chloride.Mortality for postoperative 
pancreatitis is said to be higher (up to 35%) than for other forms of 
pancreatitis”. 
HEREDITARY AND GENETIC CAUSES: 
 “Hereditary pancreatitis is an autosomal dominant disorder with 
variable penetrance. Most cases are associated with mutations in the 
cationic trypsinogen gene (PRSSI)33,35. Although more than 20 mutations 
in the trypsinogen gene have been reported, the R122H and the N291 
mutations account for the majority of cases.Mutations of CFTR in at least 
one allele occur in 2% to 37% of patients with idiopathic chronic or acute 
recurrent pancreatitis, and in a similar proportion of patients with 
recurrent acute pancreatitis associated with pancreas divisum. A third 
gene abnormality perhaps associated with pancratitis is SPINKI 
mutations. N34S mutations are the most common. The association 
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between this abnormality and pancreatitis is weak for the following 
reasons: (1) 1% to 4% of the general population have these mutations, (2) 
less than 1% of mutation carriers experience pancreatitis, and (3) the 
severity of pancreatitis is similar whether patients are homozygous, 
heterozygous, or compound heterozygous, suggesting complex 
genetics.PRSSI gene testing, CFTR genome testing, and SPINKI analysis 
are all commercially available”. 
CONTROVERSIAL CAUSES: 
Pancreas divisum: 
 “Pancreas divisum is the most common congenital malformation 
of the pancreas, occurring in 5% to 10% of the general healthy 
population. Whether pancreas divisum with normal ductular anatomy is a 
cause of acute recurrent pancreatitis continues to be a subject of 
controversy.The presumed mechanism of action in patients who 
experience pancreatitis is that there is relative obstruction to the flow of 
pancreatic juice through the minor papilla”. 
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Sphincter of oddi dysfunciton: 
 “Dysfunction of the sphincter of Oddi is also a controversial cause 
of pancreatitis.Series that study patients with recurrent acute pancreatitis 
report that sphincter of Oddi dysfunction (usually defined as pancreatic 
sphincter pressure> 40mm Hg) is the most common abnormality 
discovered, occurring in approximately 35% to 40%) of patients.The 
argument that this entity causes acute pancreatitis is based on the many 
experiential series reporting that endoscopic pancreatic sphincterotomy or 
many experiential series reporting that endoscopic pancreatic 
sphincterotomy or surgical sphincteroplasty reduces or eliminates the 
attacks of pancreatitis”. 
Miscellaneous causes: 
 “A case- control study from Denmark found a four- fold increase 
in rate of acute pancreatitis in patients with Crohn’s disease and a 1.5- 
fold increase in patients with ulcerative colitis. These findings have been 
attributed  by  some  researchers  to  the  use  of  aminosalicylates  or  
sulfasalazine. Other theories for the  inflammatory bowel disease; 
duodenal Crohn’s causes obstruction to the flow of pancreatic juice; 
granulomatous disease can invade the pancreas; there is an autoimmune 
process affecting the pancreas; and immunomodulators used to treat the 
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disease cause druginduced pancreatitis. Celiac disease has also been 
described in association with pancreatitis, but the relationship remains 
uncertain. Pancreatitis has been seen in patients who have suffered severe 
burns. A relationship between smoking and acute pancreatitis has been 
suggested”. 
CLINICAL FEATURES: 
 “It is difficult to diagnose acute pancreatitis through history and 
physical examination because clinical features are similar to those of 
many acute abdominal illness”. 
HISTORY 
Abdominal pain 
 “Abdominal pain is present at the onset of most attacks of acute 
pancreatitis, but the timing of abdominal pain varies. Biliary colic may 
herald or progress to acute pancreatitis. Pain in pancreatitis usually 
involves the entire upper abdomen. However, it may be epigastric, in the 
right upper quadrant, or, infrequently, confined to the left side. Pain in the 
lower abdomen may arise from the rapid spread of pancreatic exudation 
to  the  left  colon.  Onset  of  pain  is  rapid  but  not  as  abrupt  as  that  of  a  
perforated viscus. Usually it is at maximal intensity in 10 to 20 minutes. 
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Occasionally, pain gradually increases and takes several hours to reach 
maximum intensity. Pain is steady and moderate to very severe in 
intensity. There is little pain relief with change of body position. 
frequently, pain is unbearable, steady, and boring, band- like radiation of 
the pain to the back occurs in one half of patients. Pain that lasts only a 
few hours and then disappears suggests another disease, such as biliary 
colic or peptic ulcer. Pain is absent in 5% to 10% of attacks, and a 
painless presentation may be a feature of serious fatal disease”. 
Nausea and Vomiting: 
 “Ninety percent of patients with acute pancreatitis have nausea 
and vomiting. Vomiting may be severe, may last for hours, may be 
accompanied by retching, and may not alleviate pain. Vomiting may be 
related to severe pain or to inflammation involving the posterior gastric 
wall”. 
Physical examination: 
 “Physical findings vary according to the severity of an attack. 
Patients with mild pancreatitis may not appear acutely ill. Abdominal 
tenderness may be mild, and abdominal guarding is absent. In severe 
pancreatitis, patients look severely ill and often have abdominal 
distention, especially epigastric, which is due to gastric, small bowel, or 
35 
 
colonic ileus. Almost all patients have tenderness in the upper abdomen, 
which may be elicited by gently shaking the abdomen or by gentle 
percussion. Guarding is more marked in the upper abdomen.       
Tenderness and guarding are less than expected from the intensity of 
discomfort. Abdominal rigidity, as occurs in diffuse peritonitis, is unusual 
but can be present, and differentiating it from a perforated viscus may be 
impossible in these instances. Bowel sounds are reduced and may be 
absent. Additional abdominal findings include ecchymosis in one or both 
flanks (Turner’s sign) or abut the periumbilical area (Cullen’s sign), 
owing to extravasation of hemorrhagic pancreatic exudates to these areas. 
These signs occur in less than 1% of cases and are associated with a poor 
prognosis. Rarely, there is a brawny erythema of the flanks caused by 
extravasation of pancreatic exudates to the abdominal wall. During the 
disease a palpable epigastric mass from a pseudocyst or a large 
inflammatory mass may appear”. 
 “The general physical examination, particularly in severe 
pancreatitis, may uncover markedly abnormal vital signs if there are 
third- space fluid losses and systemic toxicity. Commonly, the pulse is 
100 to 150 beats per minute. Blood pressure can be briefly higher than 
normal and then lower than normal with third- space losses and 
hypovolemia. Initially the temperature may be normal, but within 1 to 3 
36 
 
days it may increase to 1010F to 1030F owing to the severe retroperitoneal 
inflammatory process and the release of inflammatory mediators from the 
pancreas.Tachypnea and shallow respirations may be present if 
subdiaphragmatic inflammatory exudates causes painful breathing. 
Dyspnea may accompany pleural effusions, atelectasis, congestive heart 
failure, or ARDS. Chest examination may reveal limited diaphragmatic 
excursion if abdominal pain causes splinting of the diaphragm, or 
dullness to percussion and decreased breath sounds at the lung bases if 
there is a pleural effusion. There may be disorientation, hallucinations, 
agitation, or coma, which may be due to alcohol withdrawal, hypotension, 
electrolyte imbalance, hypoxemia, fever, and/or toxic effects of 
pancreatic enzymes on the central nervous system.Icterus may be present 
due to choledocholithiasis (gallstone pancreatitis), bile duct obstruction 
from edema of the head of the pancreas, or coexistent liver disease”. 
 “Uncommon findings include subcutaneous nodular fat necrosis, 
thrombophlebitis in the legs, and polyarthritis. Subcutaneous fat necroses 
are 0.5 to 2cm, tender red nodules that usually appear over the distal 
extremities but may occur over the scalp,trunk, or buttocks. They 
occasionally precede abdominal pain or occur without abdominal pain, 
but usually they appear during a clinical episode and disappear with 
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clinical improvement. If they occur over a joint they may be confused 
with arthritis”. 
 “Some physical findings point to a specific cause of acute 
pancreatitis. Hepatomegaly, spider angiomas, and thickening of palmar 
sheaths favor alcoholic pancreatitis. Eruptive xanthomas and lipemia 
retinalis suggest hyperlipidemic pancreatitis. Parotid pain and swelling 
are features of mumps. Band keratopathy (an infiltration on the lateral 
margin of the cornea) occurs with hypecalcemia”. 
LABORATORY DIAGNOSIS: 
“Many biochemical tests have been used to diagnose acute 
pancreatitis. They can be classified as serum or uninary levels of 
pancreatic digestive enzymes, serum or urinary levels of nonenzymatic 
pancreatic secretions, nonspecific markers of inflammation, and 
miscellaneous tests. In general, the diagnosis of acute pancreatitis relies 
on at least a two- to three- fold elevation of amylase and/or lipase in the 
blood”. 
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PANCREATIC ENZYMES 
Serum and Urine Amylase 
 “In healthy persons, the pancreas accounts for 40% to 45% of 
serum amylase, and the salivary glands account for the rest. Simple 
analytic techniques can separate pancreatic and salivary amylases. 
Because pancreatic diseases increase serum pancreatic(P) isoamylase, 
measurement of P- isoamylase can improve diagnostic accuracy. This 
test, however, is rarely employed. The total serum amylase measurement 
is most commonly ordered to diagnose acute pancreatitis because it can 
be performed quickly and cheaply. The value rises within 6 to 12 hours of 
onset and is cleared fairly rapidly from the blood (half- life 10 hr). 
probably less than 25% of serum amylase is removed by the kidneys. It is 
uncertain what other processes clear amylase from the circulation. The 
serum amylase value is usually increased on the first day of symptoms, 
and it remains elevated for 3 to 5 days in uncomplicated attacks. The 
sensitivity of the serum amylase level for detecting acute pancreatitis is 
difficult to assess because an amylase elevation is often used to make the 
diagnosis. In mild attacks, other tests to detect pancreatic inflammation 
are either not sensitive enough (radiology, other biochemical markers) or 
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not necessary (surgery). A limitation of serum amylase measurement is 
that it is not 100% sensitive or specific”. 
SERUM LIPASE: 
 “The sensitivity of serum lipase measurements for the diagnosis of 
acute pancreatitis is similar to that of serum amylase measurements, 
between 85% and 100%.Some researchers claim a greater specificity than 
with serum amylase because almost all lipase originates from the 
pancreas (there is a small amount of gastric lipase), and the lipase value is 
normal when the serum amylase value is nonspecifically elevated, as in 
salivary gland dysfunction, tumors, gynecologic conditions, and 
macroamylasemia.Serum lipase content is always elevated on the first 
day of illness and remains elevated longer than serum amylase content. 
Consequently, some authorities suggest combining lipase with amylase 
values as a test for acute pancreatitis. However, the author and others 
have found that combining enzyme values does not improve diagnostic 
accuracy”. 
OTHER PANCREATIC ENZYMES: 
“During acute pancreatic inflammation, pancreatic digestive 
enzymes other than amylase and lipase leak into the systemic circulation, 
and their measurement has been used to diagnose acute pancreatitis. They 
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include PLAz, trypsin, carboxylester lipase, carboxypeptidase A, 
colipase, elastase, and ribonuclease. None, alone or in combination, is 
better than serum amylase or lipase, and measurements of most are not 
routinely available”. 
Standard blood tests: 
 “The white blood cell count is commonly elevated, markedly so in 
severe pancreatitis. The serum glucose level also may be high and may be 
associated with reductions in insulin secretion and high levels of serum 
glucagon. Aspartate aminotransferase, alanine aminotransferase, alkaline 
phosphatase, and serum bilirubin levels also may rise, particularly in 
gallstone pancreatitis”. “Pancreatic inflammation may also partially 
obstruct to distal common bile duct in acute pancreatitis from other 
causes and may cause abnormalities in liver test results.Nevertheless, 
aminotransferase measurements may distinguish between biliary and 
alcoholic pancreatitis. Serum triglyceride levels increase in acute 
pancreatitis but also with alcohol use, uncontrolled diabetes mellitus, and 
defective triglyceride metabolism”. 
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Other blood and urine tests: 
 “Many nonenzymatic proteins are over expressed in acute 
pancreatitis. Pancreatitis associated protein (PAP), a heat shock protein, is 
undetectable in the normal pancreas but its level markedly increases in 
acute pancreatitis. The sensitivity of PAP and pancreatic- specific protein 
(PSP) measurements is no better than that of conventional tests, but PAP 
and PSP values are as accurate as serum amylase value for the detection 
of acute pancreatitis”.  
“The methemalbumin level rises in acute pancreatitis, but it also 
does so in serious intra- abdominal conditions such as intestinal 
infarction”. 
RADIOLOGIC DIAGNOSIS: 
ABDOMINAL PLAIN FILM: 
 “Findings on a plain radiography range from no abnormalities in 
mild disease to localized ileus of a segment of small intestine (“sentinel 
loop”) or the “colon cutoff sign” in more severe disease and “Renal Halo” 
sign. In addition, an abdominal plain film helps exclude other causes of 
abdominal pain, such as obstruction and bowel perforation.Appearance of 
the  hollow  GI  tract  on  an  abdominal  plain  radiograph  depends  on  the  
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spread and location of pancreatic exudates. Gastric abnormalities are 
caused by exudates in the lesser sac, which produces anterior 
displacement  of  the  stomach  with  separation  of  the  contour  of  the  
stomach from the transverse colon. Abnormalities of the small intestine, 
which are due to exudates in proximity to small bowel mesentery, include 
ileus of one or more loops of jejunum (the sentinel loop), of the distal 
ileum or caecum, or of the duodenum. Generalized ileus may occur in 
severe  disease.  Other  abnormalities  of  the  hollow  GI  tract  may  also  be  
present”. 
 “Other findings on plain radiography of the abdomen may give 
clues to etiology or Severity, including calcified gallstones (gallstone 
pancratitis), pancreatic stones or calcification (chronic pancreatitis with a 
bout of acute inflammation), and ascites (severe pancreatitis). Gas in the 
retroperitoneum may suggest a pancreatic abscess”. 
CHEST RADIOGRAPHY: 
“Abnormalities visible on the chest radiographs occur in 30%of 
patients with acute pancreatitis. They include elevation of a 
hemidiaphragm, pleural effusions, basal or plate- like atelectasis 
secondary to limited respiratory excursion, and pulmonary infiltrates. 
Pleural effusions may be bilateral or confined to the left side; rarely they 
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are only on the right side. During the first 7 to 10 days, there also may be 
signs of congestive heart failure or ARDS. Pericardial effusion is rare”. 
ABDOMINAL ULTRASONOGRAPHY: 
“Abdominal ultrasonography is used during the first 24 hours of 
hospitalization to search for gallstones, dilatation of the common bile 
duct due to choledocholithiasis, and ascites. If the pancreas is seen (bowel 
gas obscures the pancreas 25% to 35% of the time), it is usually diffusely 
enlarged and hypoechoic. Less commonly there are focal hypoechoic 
areas. Evidence of chronic pancreatitis, such as intraductual or 
parenchymal calcification and dilation of the pancreatic duct, may also be 
seen. Ultra- sonography is not a good imaging modality to evaluate extra 
pancreatic spread of pancreatic inflammation or necrosis within the 
pancreas and consequently is not useful to ascertain severity of 
pancreatitis. During the course of acute pancreatitis, this modality can be 
used to evaluate progression of a pseudocyst. Because of overlying gas, 
evidence of cholelithiasis may be obscured during the acute attack but 
may be found after bowel gas has receeded”. 
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ENDOSCOPIC ULTRASONOGRAPHY: 
 “Usually, endoscopic ultrasonography (EUS) is not helpful in 
acute pancreatitis.However, it is more sensitive than either abdominal 
ultrasonography or CT to detect common duct stones. One potential use 
of  EUS  is  to  exclude  a  common  duct  stone  in  patients  with  severe  
pancreatitis and jaundice (serum bilirubin> 5mg/dL),ERCP, in this 
situation, may worsen pancreatitis and potentially introduce infection into 
necrotic areas of the pancreas. Thus, EUS might eliminate the need for 
urgent ERCP in severe gallstone pancreatitis”. 
COMPUTED TOMOGRAPHY: 
 “CT scan is the most important imaging modality for the diagnosis 
of acute pancreatitis and its intra- abdominal complications. The three 
main indications for a CT scan in acute pancreatitis are (1) to exclude 
other serious intra- abdominal conditions,such as mesenteric infarction or 
a perforated ulcer, (2) to stage the severity of acute pancreatitis, and (3) to 
determine whether complications are present, such as involvement of the 
GI tract or nearby blood vessels and organs, including liver, spleen, and 
kidney. Helical CT is the most common technique.If possible, CT 
scanning should be performed after the patient receives an oral contrast 
agent followed by an intravenous contrast agent to identify any areas of 
45 
 
pancreatic necrosis. If there is normal perfusion of the pancreas, 
interstitial pancreatitis is said to be present Pancreatic necrosis (perfusion 
defects after intra venous contrast agent is given) may not appear until 48 
to 72 hours after onset of acute pancreatitis. CT – or ultrasound- guided 
needle aspiration can confirm a suspected infections”. 
“Contraindications for using intravenous contrast agent are a 
patient’s history of prior sever allergy (respiratory distress or 
anaphylaxis) and significant renal impairment (serum creatinine 
>2mg/dL). If severe renal impairment requires dialysis, intravenous 
contrast medium may be used. Hives or less sever allergic reactions with 
previous administration of iodinated contrast material are not 
contraindications. In a patient with such a history, however, a nonionic 
contrast agent should be used; also, glucocorticoids and diphenhydramine 
(Benadryl)  should be administered before scanning”. 
“The severity of acute pancreatitis has been classified into five 
grades (A to E) on the basis of findings on unenhanced CT. Grade E 
pancreatitis represents the most severe disease. At least one half of 
patients with grade E pancreatitis have necrotizing pancreatitis. The 
majority of patients with pancreatic infection have grade E pancreatitis. 
This classification has been further refined into a CT severity index 
46 
 
(CTSI) score (Table 4). The higher the CTSI score, the more severe the 
pancreatitis clinically. Although the presence of gas in the pancreas 
suggest pancreatic infection with a gas- forming organism, this findings 
can also accompany sterile necrosis with microperforation of the gut or 
adjacent pseudocyst into the pancreas. In the great majority of pancreatic 
infections, however, CT scanning shows no gas”. 
Table 4: computed tomography (CT) Grading System of Balthazar 
and CT    severity Index scoring System (CTSI) 79 
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MAGNETIC RESONANCE  IMAGING: 
“Magnetic resonance imaging (MRI) provides information 
regarding the severity of pancreatitis similar to that given by CT. MRI is 
as good as CT in detecting necrosis and fluid collections and is a better 
method to detect choledocholithiasis and ductal disruption, especially 
after intravenous secretion is administered. Gadolinium, unlike 
intravenous contrast agents used for CT, is safe to use in renal failure. 
MRI, however, is less accessible and more expensive than CT”. 
ENDOSCOPIC RETROGRADE CHOLANGIO PANCREATICO 
GRAPHY: 
“ERCP is limited to patients with severe acute pancreatitis due to 
gallstones  with  persistent  common  bile  duct  obstruction  as  well  as  to  
those in whom the stone could not be removed during surgery”. 
DIFFERENTIAL DIAGNOSIS: 
“The differential diagnosis of acute pancreatitis include a variety of 
conditions associated with severe upper abdominal pain (Table 5). 
However, the history and physical findings aid in differential diagnosis. 
The abdominal pain of biliary colic may simulate that of acute 
pancreatitis; it is frequently severe and epigastric but lasts for several 
48 
 
hours rather than several days. The pain of a perforated ulcer is sudden, 
becomes diffuse, and precipitates a rigid abdomen; movement aggravates 
pain. Nausea or infarction, the clinical setting often is an older person 
with cardiac arrhythmia or arteriosclerotic disease who experiences 
sudden pain out of proportion to physical findings, bloody diarrhea, 
nausea, and vomiting. Abdominal tenderness may be mild to moderate, 
and muscular rigidity may not be pronounced despite severe pain. In 
intestinal obstruction, pain is cyclical, abdominal distention is prominent, 
vomiting persists and may become feculent, and peristalsis is hyperactive 
and often audible”. 
Table 5: Differential Diagnosis of Acute Pancreatitis 
Biliary pain/acute cholecystitis 
Perforated hollow viscus 
Mesenteric ischemia or infarction 
Closed- loop intestinal obstruction 
Inferior wall myocardial infarction 
Dissecting aortic aneurysm 
Ruptured ectopic pregnancy 
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PREDICTORS OF SEVERITY: 
 “Predicting severity of pancreatitis early in the course of disease is 
critical to maximize therapy and to prevent and minimize organ 
dysfunction and complications. Clinical assessment, multiple prognostic 
scoring lists(Ranson’s, Glasgow/Imrie Coma scales, APACHE II), 
peritoneal fluid analysis, organ failure scores, individual laboratory tests, 
and CT scanning have all been touted as helpful for this purpose”. 
SCORING SYSTEMS: 
Clinical signs: 
 “Clinical evidence of severe pancreatitis includes signs of 
peritonitis, shock, and respiratory distress. At 48 hours after admission 
(the height of their accuracy), sensitivity of these signs is less than 40%, 
but specificity exceeds 95%. The positive predictive value ranges from 
65% to 100%, and the negative predictive value from 74% to 87%”. 
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RANSON’S CRITERIA (TABLE 6) 
Table 6:Ranson’s 11 Prognostic Criteria for Pancreatitis 
 
 “Data from Ranson JHC, Rifkind KM, Roses DF, et al: Prognostic 
signs and the role of operative management in acute pancreatitis. Surg 
Gynecol Obstet 139:69, 1974;and Ranson JHC Etiological and prognosis 
factors in human acute pancreatitis: A review.Am J Gastroenterol 77: 
633, 1982. NA, not applicable”. 
 “Ranson and colleagues identified 11 criteria that had prognostic 
significance during the first 48 hours of pancreatitis. The original list was 
analyzed in patients who primarily suffered from alcoholic pancreatitis 
and was modified 8  years later for those with gallstone pancreatitis (see 
51 
 
Table 2). Higher Ranson’s score predicts more severe disease. In mild 
pancreatitis (score ≤2) the mortality is 2.5%, and in severe pancreatitis 
(score 2:3) the mortality is 62%. Also the higher the Ranson’s score, the 
higher the incidence of systemic complications, necrosis, and infected 
necrosis. These criteria continue to remain in wide use in both the United 
states and Europe”. 
 “The Ranson criteria have several drawbacks. First, the two lists 
are cumbersome.Second, an accurate Ranson’s score takes 48 hours to 
compute, and the criteria have not been validated beyond the 48 – hours 
time limit. Third, not all laboratories measure all the parameters in 
routine blood tests (e.g., lactic dehydrogenase). Fourth, the overall 
sensitivity  of  the  Ranson  criteria  (using  3  signs,  as,  the  cutoff)  for  
diagnosing severe disease is only 40%to 88% and the specificity 43% to 
90%. The positive predictive value is approximately 50% and the 
negative predictive value around 90%”. Therefore, the best use of 
Ranson’s criteria is to exclude severe disease78,79,82. 
THE APACHE SYSTEM: 
 “Acute physiology score and chronic health evaluation. The first 
major attempt at a system to quantify severity of illness in ICU patients 
was the APACHE system, by Knaus et al in 1981”. 
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APACHE I 
 “In the original form, APACHE contained 34 physiologic 
measurements and included many continuous variables. A value of 0 to 4 
was assigned to  each variable, according to its degree of abnormality. 
Shortly after its introduction apache 1 system was disfavoured, because 
of practical problems like collection of large number of variables. Also 
under the rules of APACHE system any unmeasured variable was 
assumed to be normal and weighted as zero. This gave rise to questions 
about the models general applicability. Another major criticism of 
original APACHE system was that the variables were chosen by a group 
of physicians and hence there was a potential of bias. These inaccuracies 
in the original APACHE system prevented its widespread use. However, 
it did serve as a prototype for the development of two subsequent 
systems”. 
SAPS 
 “The simplified acute physiology score was developed from 
APACHE I system and incorporated 13 variables that had the most 
discriminate power and were the most, frequently measured variables to 
cover  all  major  organ  systems.  SAPS  score  is  –  still  used  but  has  
essentially been replaced by APACHE II in many centres”. 
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APACHE II 
 “Published in 1985 by the same author this is the second version 
of the APACHE system and it contains refinements based on experience 
with the original APACHE system. APACHE II has been extensively 
used and has received far more attention in the literature then any of the 
other methodologies for ICU outcome prediction. It contains 12 
continuous variables from the original APACHE system and also takes 
into account age of the patient, pre- morbid conditions and Glasgow coma 
scale”. 
DEVELOPMENT OF APACHE II 
 “Using clinical judgement and documented physiologic 
relationships to choose variable and assign weights remains the essence 
of APACHE II. The number of variable were reduced from 14 to 12. 
Infrequently measured variables such as serum osmolality, lactic acid 
level, skin testing for anergy were deleted. Serum BUN was replaced by 
more specific serum creatinine and serum pH was retained in preference 
to bicarbonate. Many variables crucial in patient care, such as serum 
glucose, albumin, CVP and urinary output were found to have less 
explanatory power. Most of these variables were sensitive to variations in 
therapeutic decisions than severity of disease”. 
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 “Some of the thresholds and weights for the physiologic variables 
have been changed ego Glasgow coma score, serum creatinine. Also 
since Alveolar – arterial O2 gradient (p [A-a] O2 is heavily dependent on 
inspired O2 (F1O2) a direct weighting was given to all paO2 values when 
F1O2 is less than 0.5”. 
 “To eliminate the problem of missing values and concerns about 
the assumption that an unmeasured variable was normal, measurement of 
all 12 variables was made mandatory for usage of APACHE II. The 
recorded values of the variables are based on the most deranged values 
during the past 24 hours”. 
 “Because age and severe chronic health problems reflect 
diminished physiologic reserve, they have been directly incorporated into 
APACHE II. Also, emergency surgery and nonoperative patients with 
severe chronic organ system dysfunction were given additional five 
additional five points in comparison to elective surgical patients who 
were given only two points because patients with severe chronic 
conditions are not considered to be candidates for elective surgery. The 
maximum  possible  APACHE  II  score  is  71.  In  the  experience  of  the  
author of APACHE II no patient had exceeded 55”. “The strengths of 
APACHE II system are 
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i. It has a well defined outcome (hospital death) 
ii. It was derived from a large database (5815 patients from 13 
hospitals) 
iii. Source of bias present in its prototype was understood and 
corrected”. 
“Short comings of APACHE II system. 
Because of extensive usage, important sources of error and bias in 
the APACHE II system were revealed. First, APACHE II performs well 
overall in several ICU population but it is inaccurate when looking at 
specific disease categories because the data base from which it was 
derived, through large, did not contain many patients in major disease 
subsets such as cardiac surgery, oncology etc. Second APACHE II does 
not account for prior treatment or clinical course before the patient enters 
ICU, this has been labeled as lead time bias. Third, APACHE II requires 
determination of a single admission diagnosis, a subjective process prone 
to bias. Finally, despite the reduction in number of variables, 
measurement error from bedside data collection are still on issue”. 
 “APACHE II has been recently refined into APACHE 0, where 0 
represents obesity, and this is a better predictor of prognosis than 
APACHE  II.  Another  modification  of  APACHE  II  is  the  APACHE  III  
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system which is now being applied widely to acute pancreatitis clinical 
trials”. 
“APACHE II has the advantage of being able to be used on a daily 
basis and its positive and negative predictive values are similar to those of 
the  Ranson  score  at  48  hours  after  admission.  The  Apache  II  system  
assigns points for 12 physiologic variables, for age, and for chronic health 
status, in generating a total point score. The 12 physiologic variables are 
temperature, heart rate, respiratory rate, mean arterial blood pressure, 
oxygenation, arterial pH, serum potassium, sodium and creatinine values, 
hematocrit, white blood cell count, and Glasgow Coma Scale. APACHE 
II scores on admission and within48 hours help distinguish mild from 
severe pancreatitis and to predict death. Most patients whose APACHE II 
scores are 9 or less during the first 48 hours survive. However, patients 
with APACHE II scores of 13 or more have a high likelihood of dying. 
At  admission,  sensitivity  of  the  APACHE  II  score  is  34%  to  70%,  and  
specificity is 76% to 98%. At 48 hours, sensitivity remains less than 50%, 
but specificity is close to 90% to 100%. Strong drawbacks of the 
APACHE II score are its complexity, its low sensitivity on admission, 
and the fact that at 48 hours it is no better than other scoring systems”. 
Like the Ranson criteria, the APACHE II score has its highest value in 
predicting mild disease79,82,83. 
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Table 7: Acute Physiology and Chronic Health Evaluation 
(APACHE)- II Scoring System of Disease Severity 
 
 
Glasgow Score 
          “The Glasgow score is a slightly simplified list (8criteria) that is 
used commonly in the United Kingdom. Its drawbacks are similar to 
those of the Ranson score.Other investigators evaluated organ 
dysfunction risk factors in a qualitative way and found that the presence 
of one risk factor predicted serious complications and more than 50 % 
mortality”. 
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Table 8: Modified Glasgow Criteria: Within 48 Hours of Admission 
 
 
Organ Failure Scores: 
 “Organ failure precedes death in the great majority of patients with 
acute  pancreatitis. The Atlanta criteria (Table 1) define severe disease 
and enumerate various organs that are susceptible to failure but make no 
distinction between single- and multiple organ failure or between 
transient and persistent organ failure. The Atlanta criteria thus cannot be 
used to prognosticate. Multiple- organ failure or organ failure that is 
persistent should render a patient more susceptible to death than single- 
organ or transient organ failure. Therefore, criteria that attempt to 
qualitatively or quantitatively score organ failure might be more 
predictive of a fatal outcome than other parameters. The Goris score 
assigns an organ failure value of  0,  1 or  2 or  each of  seven main Organ 
system (respiratory, renal, cardiovascular, hepatic, central nervous, 
hematopoietic, and GI). A score of 14 is the maximum and indicates 
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severe disease in all systems.A study from Scotland demonstrated that the 
Goris score was more predictive of death than the Glasgow/Imrie score. 
In this study of 279 patients with acute pancreatitis, there were no deaths 
in 189 patients with a Goris score of 0, 7 deaths (9%) in the 75 patients 
with a Goris score of 1 to 4, and 10 deaths (67%) in the 15 patients with a 
score higher than 5.Greater use of organ failure scores are likely to 
improve prognostication in acute pancreatitis”. 
PERITONEAL LAVAGE 
 “Percutaneous recovery of any volume of peritoneal fluid with a 
dark color or recovery of at least 20mL of free intraperitoneal fluid of 
dark color portends a significant mortality. The sensitivity of peritoneal 
lavage is 36% to 72%, and the specificity is greater than 80% to 100%. 
An advantage is that peritoneal lavage can be used any time, but it has not 
gained wide acceptance because it is invasive”. 
LABORATORY MARKERS: 
 “The extent of elevation of serum amylase concentration does not 
distinguish mild from severe pancreatitis. Admission or 24 – hour 
hematocrit levels may be helpful in distinguishing severe disease, as may 
the CRP value. Although not generally available clinically, measurements 
of IL- 6, polymorphonuclear leukocyte elastase, PLAz, TAP, serum 
60 
 
amyloid A, and procalcitonin may prove valuable because their 
concentrations in blood or urine may serve to separate mild from severe 
acute pancreatitis”. 
“Hematocrit value: A high hematocrit value on admission or failure of a 
high value to diminish after 24 hours of rehydration is believed to be a 
sing of hemoconcentration due to retroperitoneal fluid loss and thus a 
marker of severe disease. One study showed that a hematocrit higher than 
44% had a sensitivity of 72% on admission and of 94% after 24 hours for 
detection of organ failure. The negative predictive value at 24 hours was 
96%.74 However, another study from Germany found no correlation 
between admission hematocrit value and o rgan failure”. 
“C-Reactive Protein: Measurement of CRP, an acute – phase reactant 
produced by the liver, is used extensively in Europe as a marker of severe 
pancreatitis. CRP is inexpensive to measure and readily available. The 
sensitivity for detecting severe disease is 60% to 100% (with cutoffs of 
100-210mg/L), and the specificity is 75% to 100%”. 
“Interleukin – 6: IL 6 is an acute- phase reactant cytokine that is 
produced  by  a  variety  of  cells  and  induces  hepatic  synthesis  of  CRP.  
Several studies have shown that it is a reasonably good marker to 
differentiate mild from severe pancreatic disease”. 
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“Polymorphonuclear leukocyte Elastase: Polymorphonuclear leukocyte 
elastase rises very early (before CRP) in acute pancreatitis. High levels 
have been reported to differentiate severe from mild disease, but the test 
is not generally available”. 
“Phospholipse A2: PLAz is involved in the synthesis of prostaglandins 
and degrades surfactant in the lung. It may play a role in the pulmonary 
dysfunction associated with acute pancreatitis. Levels of catalytic type II 
PLAz have been reported to differentiate between mild and severe disease 
within 24 hours of admission”. 
“Urinary Trypsinogen activation peptide: TAP is the aminoterminal 
peptide cleaved from trypsinogen during activation of trypsin, providing a 
rationale for its use as a marker of acute pancreatitis. It can be measured 
in plasma, ascites fluid, and urine. The urinary TAP level appears to be 
the most useful and, if measured within 24 hours of onset of symptoms, 
distinguishes mild from severe pancreatitis. The sensitivity, specificity, 
and positive and negative predictive values  of  TAP  measurement  for  
distinguishing severe from mild acute pancreatitis at 24hours compare 
favorably with those for CRP value and APACHE II, Ranson, and 
Glasgow scores.A serum and urinary carboxypeptidase activation peptide 
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(CAPAP) assay has also been shown to predict early severe acute 
pancreatitis”. 
“Serum Amyloid A: Serum amyloid A is another early acute- phase 
reactant that is synthesized in the liver and is associated with the extent of 
tissue inflammation. Two studies have demonstrated that the level of this 
serum protein can differentiate mild from severe disease”. 
“Procalcitonin: The pro peptide procalcitonin is another acute- phase 
reactant that has been shown to differentiate mild from severe acute 
pancreatitis within the first 24, hours after symptom onset. A serum strip 
test has been developed for this measurement that has a sensitivity of 
86% and a specificity of 95% in detecting organ failure”. 
COMPUTED TOMOGRAPHY: 
 “CT scanning has been used to assess severity of pancreatitis. The 
finding of extensive fluid collections or extensive necrosis has been 
correlated with severe disease.In an early study, Balthazar and colleagues 
LIS showed that death occurred in 5 of 37 (13.5%) patients who had 
grade D or grade E findings on CT (table 5), as opposed to a of 51 who 
had grades A through C findings. When assessed with CTSI score (see 
Table  5),  3  of  77  patients  (3.8%)  with  scores  of  a  through  6  died,  as  
opposed to 2 of 11 (18%) with scores 7 through 10. The CT grading 
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scores correlate better with local complications (pseudocysts and 
abscesses) than with mortality. Among the 37 patients with grade D or E 
findings, 54% had a local complication, whereas only 2 of 51 (3.9%) with 
grades A through C experienced this problem. Thus, the data do not 
confirm that the CTSI is any more predictive than the grade A-E score. 
There is controversy in the literature as to whether the extent of necrosis 
on CT predicts organ failure. Two studies did not find any correlation 
between these two events.  In a third study,  however,  there was a strong 
correlation”. 
CHEST RADIOGRAPHY 
 “A pleural effusion documented within 72 hours of admission by 
either chest radiograph or CT scan correlates with severe disease”. 
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TREATMENT 
GENERAL CONSIDERATIONS: 
 “The patient with acute pancreatitis requires aggressive 
intravenous hydration and adequate analgesia to eliminate or markedly 
reduce pain. An order for no oral intake (NPO) is usually in force until 
nausea and vomiting have subsided. Abdominal pain is treated with 
analgesics, given parenterally every 3 hours. Morphine can also be 
used.Dosing is monitored carefully and adjusted daily according to 
ongoing needs. Although morphine has been reported to increase 
sphincter of Oddi tone and to raise serum amylase levels, its use to treat 
the pain of pancreatitis has not been shown to adversely affect outcome. 
Nasogastric intubation is not used routinely because it is not beneficial in 
mild pancreatitis. This modality is used only to treat gastric or intestinal 
ileus or intractable nausea and vomiting. Similarly, proton pump 
inhibitors and histamine Hz receptor blocking agents are not beneficial 
and are not used”. 
 “Each patient should be carefully monitored for any signs of early 
organ failure such as hypotension and pulmonary or renal insufficiency 
via close following of vital sings and urinary output. Rapid respiratory 
rate should not be assumed to be due to abdominal pain, and blood gas 
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measurements and oxygen supplementation are mandatory in this 
situation. In cannot be overly emphasized that any patient who exhibits 
signs of early organ dysfunction should be immediately transferred to 
intensive care monitoring because deterioration can be rapid and fatal. 
This may be one of the most important decisions the clinician must 
make”. 
FLUID RESUSCITATION: 
“Maintaining adequate intravascular volume in severe disease may 
require 5 to 10 liters of fluid (e.g., isotonic saline) daily for the first 
several days. A Swan- Ganz catheter is useful to gauge fluid resuscitation 
and to avoid fluid overload and congestive heart failure. It is also helpful 
when cardiovascular status is unstable or respiratory function 
deteriorates. Aggressive fluid replacement may not prevent pancreatic 
necrosis.Experimentally, hemodilution to a hematocrit value of around 
30% with dextran 60 solution improved the pancreatic microcirculation 
and oxygenation. When the hematocrit decreased to around 259%, 
packed red blood cells should be infused to maintain a hematocrit close to 
30%”. 
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RESPIRATORY CARE: 
 “Hypoxemia (oxygen saturation < 90%) requires oxygen, ideally 
administered via nasal prongs or face mask if needed. If nasally 
administered oxygen fails to correct hypoxemia or if the patient has 
fatigue and borderline respiratory reserve, endotracheal intubation and 
assisted ventilation are required early. It is important to use a Swan – 
Ganz catheter to determine whether hypoxemia is due to congestive heart 
failure (increased pulmonary artery wedge” pressure) or is a primary 
pulmonary problem (normal or low pulmonary artery wedge pressure). 
ARDS is the mot serious respiratory complication of acute pancreatitis 
because it is associated with severe dyspnoea, progressive hypoxemia, 
and higher mortality. It generally occurs between the second and seventh 
days of illness, although it can be present on admission, and consists of 
increased alveolar capillary permeability causing interstitial edema. Chest 
radiography may show multilobar pulmonary infiltrates. Treatment is 
endotracheal intubation with positive end- expiratory pressure ventilation. 
No specific treatment prevents of affects this condition. After resolution, 
pulmonary structure and function usually return to normal”. 
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CARDIOVASCULAR CARE: 
 “Cardiac complications of severe acute pancreatitis include 
congestive heart failure, myocardial infarction, cardiac arrhythmia, and 
cardiogenic shock. An increase in cardiac index and a decrease in total 
peripheral resistance may be present; they respond to infusion of 
crystalloids. If hypotension persists even with appropriate fluid 
resuscitation, intravenous dopamine may help maintain the systemic 
blood pressure. Unlike other vasoconstrictors, dopamine does not impair 
the microcirculation of the pancreas”. 
METABOLIC COMPLICATIONS: 
 “Hyperglycemia may manifest during the first several days of 
severe pancreatitis but usually normalizes as the inflammatory process 
subsides. Blood sugar levels fluctuate widely, and insulin should be 
administered cautiously. Hypocalcemia due to low serum albumin 
concentration causes no symptoms and requires no specific therapy. 
However, reduced serum ionized calcium may cause neuromuscular 
irritability. If the patient also has hypomagnesemia, magnesium 
replacement should restore serum calcium level to normal. Causes of 
magnesium depletion include vomiting, loss of magnesium in urine, and 
deposition of magnesium in areas of fat necrosis. When serum 
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magnesium concentration is normal, hypercalcemia with signs or 
symptoms of neuromuscular irritability requires intravenous 
administration of calcium gluconate if the serum potassium level is 
normal and the patient is not receiving digitalis. Intravenous calcium 
increases calcium binding to myocardial receptors, displacing potassium 
and possibly inducing a serious arrhythmia”. 
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ALGORITHM FOR MANAGEMENT OF ACUTE 
PANCREATITIS 
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ANTIBIOTICS64 
       “Antibiotics are not needed in mild pancreatitis. However, pancreatic 
infection(infected necrosis and, less so, abscess) and nonpancreatic sepsis 
(line sepsis, urosepsis or pneumonia) are major sources of morbidity and 
mortality in severe acute pancreatitis.Thus, it would seem logical to 
consider antibiotic prophylaxis to improve the outcome”. 
Table 9: Prospective, Randomized Prophylactic Antibiotic Trials in 
Acute pancreatitis 
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ENDOSCOPIC THERAPY 
Urgent Removal of gallstones in gallstone pancreatitis 
 “Early removal of a possibly impacted gallstone to improve the 
outcome of gallstone pancreatitis remains a controversial issue. There 
have been three randomized  fully published studies comparing urgent 
ERCP and sphincterotomy (for any retained stone) with conventional 
treatment in the management of gallstone pancreatitis. The earliest study, 
a single- center investigation from England found, that urgent ERCP 
performed within 72 hours of admission improved the outcome 
(complications and mortality) of patients with severe but not mild, acute 
gallstone pancreatitis. A single center study from Hong Kong, found that 
the group in whom urgent ERCP was performed had lower rates of biliary 
sepsis and showed a trend toward lower morality than the control group. 
The third and largest study, from Germany, involved 22 centers and 
found a higher complication rate and worsened mortality trend in the 
urgently treated ERCP group than in the group undergoing standard 
nonurgent therapy210. Differences in the designs of these studies do not 
allow direct comparisons. It can be said, however, that there is consensus 
that severe acute gallstone pancreatitis with ascending cholangitis 
(jaundice and fever) is an indication for urgent ERCP. However, f severe 
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pancreatitis is unaccompanied by cholangitis, results of the German study 
would suggest withholding ERCP, whereas those of the English study 
would suggest proceeding with urgent early ERCP”. 
Endoscopic Therapy of Pancreatic Duct Rupture 
 “Pancreatic ductal rupture leading to peri pancreatic fluid 
collections is common in necrotizing pancreatitis. In a prospective ERCP 
study of biliary pancreatitis, Uomo and colleagues SO noted a 30.5% rate 
of main pancreatic duct leakage. It has been proposed that early 
endoscopic stenting of the main pancreatic duct in patients with this 
problem  may shorten hospital stay and reduce the need for subsequent 
necrosectomy. No controlled studies have yet been reported, and there is 
the theoretical concern that stenting may cause infection of a sterile fluid 
collection”. 
NUTRITIONAL THERAPY 
 “Mild pancreatitis does not require special nutritional feedings. 
Intravenous hydration is continued until the patient no longer has 
significant abdominal pain, nausea  or vomiting. Oral feedings can then 
be initiated. The question as to which factors can predict which patients 
will show poor response to refeeding was addressed by one study.One 
hundred sixteen patients with acute pancreatitis were fed at the clinician’s 
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discretion.Twenty-one percent of patients has pain on refeeding of 250 
kcal/day. Those who did so nearly doubled ‘ their stay in the hospital 
(33vs. 18 days) compared with those in whom pain did not reappear. A 
prefeeding serum lipase level more than three- fold higher than normal 
doubled the risk of a pain relapse with refeeding (39%, versus 16% in 
those with normal serum lipase). However, most patients with lipase 
values that high prior to refeeding did not have pain with refeeding. 
These observational data are insufficient to guide clinicians as to when to 
start refeeding. Serum lipase can remain elevated for long periods after 
pancreatitis, and it seems reasonable to feed the ‘patient clear’ liquids- 
with no or very few calories when pain and nausea have subsided without 
regard to the enzyme levels. The diet can then be advanced slowly as 
tolerated”. 
 “In patients with more severe pancreatitis, total parenteral 
nutrition (TPN) initially has appeal because it allows the pancreas to 
remain completely at rest while the patient’s nutritional needs are met, 
But comparisons between TPN and either intravenous peripheral nutrition 
or enteral nutrition have shown that TPN is more expensive and carries a 
higher complication rate. Sax and associates randomly assigned 54 
patients with mild pancreatitis to either intravenous nutrition of TPN. The 
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latter group had a higher number of septic complications and a longer 
hospitalization”. 
 “McClave and coworkers randomly assigned 30, patients with 
mild or moderate pancreatitis to TPN “or” enteral feedings administered 
through a nasoenteric tube beginning 48 hours after admission. The 
Ranson and APACHE II scores and glucose levels normalized more 
quickly in the enteral group, and the length of hospitalization in that 
group showed a trend toward a shorter stay. Windor and colleagues 
randomly assigned 34 patients as follows; those with mild/moderate 
pancreatitis to either oral feedings or TPN, and those with severe 
pancreatitis to either enteral feedings via a nasoenteric tube or TPN. The 
group receiving oral/enteral feedings has shorter ICU stays and showed 
improvements in acute- phase response markers and disease severity 
scores compared with the TPN group, finally, Kalfarentzos and associates 
randomly assigned 38 patients with sever necrotizing pancreatitis to 
either TPN or nasoenteric feedings. The enteral nutrition group had fewer 
septic complications and fewer total complications, although duration of 
hospital stay, duration of ICU stay, and days until resumption of regular 
diet were the same in the two groups”. 
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 “Thus these studies demonstrate that enteral nutrition is cheaper 
and safer and is preferable in patients with severe acute pancreatitis. 
When nutrition should be initiated and for how long it must be continued, 
however, are still not established. Furthermore it is unclear whether 
nasoenteric feedings are needed or whether nasogastric or even oral 
feedings are similarly effective if the patient tolerates this modality. 
Along those lines, a UK group randomly assigned 50 patients with severe 
pancreatitis to either nasogastric or nasoenteric tube feedings. No 
difference between the groups was seen in the ability to tolerate feedings, 
in markers of inflammation, or in morbidity or mortality”. 
SURGERY 
“The  role  of  the  surgeon  is  primarily  two-  fold  in  pancreatitis,  to  
remove the gallbladder in cases of gallstone pancreatitis and to debride 
pancreatic necrosis or drain a pancreatic abscess if these complications 
develop. A consensus conference of surgical guidelines suggested in 2002 
that in mild and severe gallstone pancreatitis, cholecystectomy should be 
performed as soon as the patient has recovered and the inflammatory 
process has subsided, with regard to pancreatic necrosectomy, the data 
are more complicated. Studies in the 1980s suggested improved mortality 
with early necrosecfomy (within the first week of hospitalization for 
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severe disease). However, in the only randomized study comparing early 
(within 72 hours of admission) with late (>12 days after admission) 
necrosectomy, the mortality was higher after early operation than after 
later debridement (56% vs. 27%)”. 
 “Some investigators have reported that it is important to, 
differentiate sterile necrosis from infected necrosis via fine needle 
aspiration of the pancreas. Sterile necrosis scan be managed 
nonoperativley, because the mortality rate of this condition without 
surgery is less than 5%. Infected necrosis (as documented by fine- needle 
aspiration of the pancreas), however, is widely regarded as an indication 
for immediate surgical debridement because of the belief that infected 
necrosis treated medically has a nearly uniform fatal outcome. On the 
other hand, surgical therapy of infected pancreatic necrosis carried a 
substantial mortality rate, 15% to 73%. This fact has led to the 
recommendation that patients who are into showing improvement with 
maximal medical therapy or who show new signs of organ failure should 
undergo fine needle aspiration of the pancreas”. 
 “The finding of infection should then lead to immediate surgical 
intervention. One surgical team, however, had demonstrated that the 
timing of surgery, not the bacteriologic status of the pancreas, determines 
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surgical mortality. This group operated a mean of 31 days after onset of 
illness (considerably later than most groups) and documented only a 6.2% 
surgical mortality with no difference in mortality between patients with 
sterile and infected necrosis; these results are corroborated by another 
surgical team who compared early necrosectomy (a mean of 5.6 days 
after symptoms) with late necrosectomy (mean of 16.6 days after 
symptoms). Earlier operation was associated with a much higher 
mortality than delayed surgery (42% vs. 14%) whether infected or sterile 
necrosis was present. These studies suggest that delaying operation to 
allow for the acute inflammatory process to subside improves mortality 
whether or not infection is present”. 
 “The natural history of infected necrosis remains largely unknown 
because of the prevailing propensity for clinicians to operate immediately 
or to use other forms of drainage on documentation of such infection. In 
small case series and one larger series, however, survival has been 
achieved with antibiotic therapy alone. Fine needle aspiration in these 
series led to appropriate changes of antibiotics. No controlled studies in 
this area have been performed. Clearly, the management of infected 
necrosis requires further definition by studies the elucidate its natural 
history. Necrosectomy also appears to have deleterious effects on long- 
term exocrine and endocrine function of the pancreas compared with no 
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necrosectomy. Thus, if at all possible, surgical necrosectomy for sterile or 
infected necrosis should be avoided unless the patient does not experience 
improvement. If intervention is needed, delaying until the fourth week or 
later is advisable. Drainage of a pancreatic abscess by surgical, 
radiologic, or occasionally, endoscopic approaches is advised. Unlike 
pancreatic infected necrosis, a pancreatic abscess is a poorly marginated 
collection of pus near the pancreas that appears on CT scanning as a low 
density mass that may contain air bublles. The cause may be secondary 
liquefaction and secondary infection of an area of necrosis or infectin of a 
pancreatic pseudocyst. Most pancreatic abscesses occur later than 
infected necrosis, at least 4 weeks after the onset of acute pancreatitis. In 
general, the mortality of a pancreatic abscess is less than that o infected 
necrosis”. 
OTHER APPROACHES OF QUESTIONABLE EFFICACY 
 “Pancreatic protease inhibitors have been used to treat established 
severe acute pancreatitis and to prevent post ERCP pancreatitis. Gabexate 
mesylate is the most wide studied pancreatic protease inhibitor. A meta- 
analysis of five clinical trials of gabexate mesylate in acute pancreatitis 
found no effect on the 90- day mortality rate but a lower incidence of 
complications. Multiple trials of somatostatin or its synthetic analog, 
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octreotide, have failed to show convincing evidence of efficacy in the 
treatment of acute pancreatitis. The use of anti- inflammatory cytokines 
has so far not been beneficial. The largest experience has been with 
lexipafant, a PAF inhibitor, after initial promising reports, subsequent 
studies have not shown clear efficacy”. 
 “Japanese investigators have suggested that, pancreatic protease 
inhibitors and antibiotics can be better targeted to the affected regions in 
the pancreas with continuous regional arterial infusion (CRAI) into the 
celiac, splenic, inferior pancreaticoduodenal, and common hepatic 
arteries.  Using  CT,  Anai  and  colleagues  showed  that  with  CRAI,  the  
contrast material was distributed to the entire pancreas in six of nine 
patients with inflammation of the entire pancreas; in the remaining three 
patients, contrast material did not penetrate the entire area of pancreatic 
inflammation. Two later studies suggested that intra- arterial infusion of 
protease inhibitor (nafamostat mesylate) plus imipenem reduces mortality 
compared with intravenous infusion of the same agents. These studies 
warrant further investigations. In randomized studies, many other 
measures have been ineffective, including anticholinergics, glucagon, 
fresh frozen plasma, and peritoneal lavage”. 
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COMPLICATIONS: 
 “The complications of acute pancreatitis can be divided into local 
complications secondary to the inflammatory process in the 
retroperitoneum and systemic complications (table 10)”. 
Table 10- complications of acute pancreatitis 
 
Methodology 
  
81 
 
METHODOLOGY 
The present study is a prospective study of 33 cases of Acute 
pancreatitis admitted in Rajiv Gandhi Government General Hospital, 
Chennai, during the study period of July 2014 to Sep 2014. 33 cases for 
the purpose of the study were selected on the basis of the non probability 
(purposive) sampling method. 
Source of study : 
All patients diagnosed with acute pancreatitis admitted in Rajiv 
Gandhi Government General Hospital, Chennai 
Inclusion criteria : 
All patients diagnosed with acute pancreatitis based on the clinical 
suspicion and elevated serum amylase 
Exclusion criteria : 
· hyperamylasaemia due to other causes 
· chronic pancreatitis 
· acute on chronic pancreatitis 
· previously diagnosed case of acute pancreatitis 
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Method of collection of data : 
All patients diagnosed with acute pancreatitis based on the clinical 
suspicion and increased serum amylase levels admitted in Rajiv Gandhi 
Government General Hospital, Chennai are assessed with multiple 
clinical and laboratory variables of both Ranson and Apache II scoring 
system and the final score of the patient from both the scoring systems 
are assessed to know their efficacy in predicting the severity of the 
disease (higher the score more severe the disease). 
The sensitivity, specificity, positive predictive value and negative 
predictive value of Ranson and Apache II scoring system in relation to 
the raised serum amylase level were evaluated and compared with 
standard published literature. 
STATISTICAL METHODS APPLIED : 
Data was analysed statistically using WILCOXON SIGN RANK 
TEST and FISHERS EXACT TEST by SPSS version 17. 
P<0.05 was considered to be significant. 
 
 
 
Observations & 
Results 
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OBSERVATION AND RESULTS 
A total of 33 patients were included in the study. 
All had an admitting diagnosis of acute pancreatitis 
All 33 patients fulfilled the inclusion criteria: 
· clinical suspicion of pancreatitis 
· increased amylase 
· features of Pancreatitis on USG ABDOMEN 
Of the 33 patients, age range was 28-60 years (mean-44 years), 
20(60.6 %) were men and 13(39.39%) women. The causes of acute 
pancreatitis included biliary stone 14(42.4%), alcoholism 10(30.3%), 
idiopathic 9(27.2%). 6(18.1%) patients were chronic smokers and 
8(24.2%) had atleast one co-morbid disease. The common concomitant 
diseases were hypertension (37.5%), diabetes mellitus (25%), ischaemic 
heart disease (5%). 
Over all, 8(24.2%) patients suffered from severe pancreatitis and 
25(75.7%) had mild acute pancreatitis of which all 8 had severe attack as 
per APACHE II score (>8) and only 3 of these were considered severe by 
RANSON score (>3). The systemic complications were multiorgan 
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failure in 2(6.06%), respiratory 1(3.03%) and renal 1(3.03%) all seen in 
patients  with  severe  score  as  per  APACHE  II  .  No  death  occurred  and  
mortality was nil. Local complications occurred in 2 patients (6.06%) and 
both had acute fluid collection. All the complications were seen in 
patients with severe score as per APACHE II and none as per RANSON 
score. 
RANSON Scores: 
Table 11: Ranson scoring system results 
Score Frequency Percentage 
< 3 30 90.9% 
3 - 4 3 9.09% 
5 - 6 Nil - 
> 6 Nil - 
Total 33 100% 
 
(Score >3 suggests severe pancreatitis) 
       In our study only 3 patients had score more than 3, suggesting that 
only 9.09 % of them were considered to be having severe pancreatitis as 
per Ransons criteria. 
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APACHE II Scores: 
Table 12: Apache II scoring system results 
Score Frequency Percentage 
0 – 5 24 72.7% 
                6 – 10 6 18.18% 
    11 - 15 3 9% 
                   >15 Nil                    - 
Total 33 100% 
 
(Score > 8 suggest severe pancreatitis ) 
In our study 8 patients were diagnosed to have score more than 8 of 
the 33 cases, suggesting that 24.24 % had severe pancreatitis as per 
Apache II scoring criteria. 
Data was analysed using Wilcoxon sign rank test & Fishers exact 
test. The value at cut off point was expressed as sensitivity, specificity, 
ppv, npv & area under the ROC curve. P<0.05 was considered to be 
significant 
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Table 13 : Analysed data of Ranson and Apache II scores 
Severity of 
acute 
Pancreatitis 
Scores 
Median 
 
Interquartile 
Range 
Z P 
ApacheII 2 7 4.491 <0.0005 
Ranson 0 1 
 
 
 
 
Graph: 1 
 
 
87 
 
Table 14 : Ranson – patient frequency 
 Frequency Percent 
Valid      Mild 
 
Severe 
 
Total 
30 
 
3 
 
33 
90.9 
 
9.1 
 
100.0 
 
 
Table 15 : Apache II - patient frequency 
 
 Frequency Percent 
Valid      Mild 
 
Severe 
 
Total 
25 
 
8 
 
33 
75.8 
 
24.2 
 
          100.0 
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Table 16: Percentage table (both scoring system together) 
 
p=0.01 
 
 
Graph: 2 
(Percentage of mild and severe pancreatitis) 
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APACHE II 
Table 17: Predictive performance: Area under curve= 0.717 
 
P<0.0005 
 
Sensitivity= 100% 
Specificity=80% 
ppv=62% 
npv=100% 
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Ranson 
Table 18 : Predictive performance :- Area under curve= 0.667 
 
P<0.0005 
 
Sensitivity= 66.7% 
Specificity= 86.7% 
Ppv =33% 
Npv =96% 
 
 
 
Discussion 
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DISCUSSION 
 “Severe acute pancreatitis ususally declares itself shortly after the 
onset of symptoms and delayed progression from mild to severe disease 
is uncommon9. Assessment of the severity of acute pancreatitis is 
important for early identification of patients who may benefit from 
additional supportive and specific therapeutic procedures.It is also 
important to standardize clinical data for comparision of results between 
centres1,10. Ideal predicting criteria should therefore be simple, non-
invasive,accurate and quantitative, and the assessment tests should be 
readily available at the time of diagnosis.Amongst the multi factorial 
scorine systems, Ranson system is classical though the Apache II system 
appears to provide the best accuracy” . 
 “This study has demonstrated that the Apache II scoring system is 
better than the Ranson system in predicting the severity of acute 
pancreatitis. The AUC of Apache II score was 0.717 and that of Ranson 
was 0.667 , Sensitivity of Apache II was 100% and that of Ranson 66.7%, 
Specificity of Apache II was 80% and Ranson 86.7% , ppv of ApacheII 
62% and Ranson 33% , npv of Apache II 100% and Rason 96% 
respectively”. 
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 “The incidence of acute severe pancreatitis in this study was 
24.2% (8cases), Apache II score showed 75.8 % mild(23cases) & 24.2% 
(8cases) severe pancretitis and Ranson score showed 91.1% 
(30cases)mild & 9.09% (3cases)severe .These results were probably due 
to Apache II system having more number of variables and also incudes 
the chronic health status of the pateint than the Ranson scoring system 
resulting in Apache II being more accurate in predicting the severity of 
pancreatitis”.  
 “In a study done by Yeung YP6, the results are follows. It is 
compared with present study.82” 
 
Table 19: Comparision of AGE in present study with standard 
literature 
 
AGE(years ) Present study (33 
cases) 
Yeung .Y. p study (101 
cases) 
Mean Age in years 44years 68years 
Range 28-60years 20 -96 years 
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Table 20: Comparision of the SEX in present study with standard 
literature 
 
SEX Present study Yeung.Y.P study 
Male 20 (60.6%) 43(42.6%) 
Female 13 (39.3 %) 58(57.4%) 
 
Table 21:Comparision of the causative factors 
 
CAUSE 
 
Present Study Yeung .Y.P study 
 
Biliary stones 14(42.4%) 59(58.4%) 
Alcohol 10(30.3%) 3(3.0%) 
Idiopathic 9(27.2%) 23(22.8%) 
Other factors Nil 16(15.8%) 
 
 
 “In this study, acute pancreatitis was found more commonly in 
males than females; male: female ratio being 60.6%:31.3% and mean age 
was 44years. These results can be compared to the Savio G Barreto and 
Jude Rodrigues study where the male female ratio was 96.1%:3.9% and 
mean age was 40 years, by Kimmo I. Halonena et al it was 83.7:16.3 and 
mean age was 43.62 yrs indicating increased incidence in males and also 
the 4th decade of life being most frequent incidence of age group71,72. In 
the present study alcohol was the etiological factor in 30.3% of patients 
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and gallstones in 42.4% compared to alcohol being 92.6% and gallstones 
19% in Savio G Barreto and Jude Rodrigues study and in Kimmo I. 
Halonena et al study alcohol accounted to 79.1% and gall stones to 13.2% 
showing that alcohol is most frequently the etiological factor”.71,72  
 “Of the 33 patients, 23(69.69%) had mild disease while 8 
(24.24%) had severe disease (based on Atlanta Criteria for Severe Acute 
Pancreatitis; APACHE II score > 8 was considered severe,and RANSON 
score>3 was severe). In Savio G Barreto and Jude Rodrigues study 67% 
had mild disease while 33% patients had severe disease. 74.07% had mild 
disease and 25.93% had severe disease in Abbasi J. Akhtar et al study” 
73,71.  
“The overall mortality rate was nil as compared to Savio G Barreto 
and Jude Rodrigues study where the overall moratlity was 12% and 14% 
in Abbasi J. Akhtar et al study 73,71.Comparing outcomes in patient groups 
based  on  a  range  of  APACHE  II  scores,  it  was  observed  that  
complications like acute fluid collection, major organ failure were more 
common when APACHE II scores exceeded 10 and patients considered 
severe as  per RANSON score had no complications”.82 
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“Contrary to expectation, pseudocysts were observed in 2 patients 
whose APACHE II scores on admission were less than 5. These patients 
presented to the hospital later than 48 hours after the onset of symptoms 
by which time the severity of the attack may have subsided and the 
recorded scores were spuriously low”.  
“The sensitivity, specificity, positive predictive value and negative 
predictive value were comparable with other studies in prediction of 
severity. On admission APACHE II  scores were very sensitive for 
prediction of major organ failure”. 
 
Table 22: Comparison with other Studies 71,72,82,81 
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          “The  APACHE  II  system  is  the  only  system  which  takes  into  
account all the major risk factors that influence outcome from disease, 
including the acute physiological derangements as well as patient ability 
to recover which may be diminished by advancing age or chronic disease. 
The range of APACHE II score is wide providing better spread between 
mild and severe attacks, because varying weights are assigned to 
increasingly abnormal values, rather than all or none judgements than 
RANSON scoring system”. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
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CONCLUSION 
 “The study include 33 patients (M:F=20:13) with acute 
pancreatitis, peak incidence was in the fourth decade with alcohol 
accounting for 30.3% of the attacks while gall stones accounted for 
40.4%”.  
 “An  APACHE  II  score  of  ≥ 10  on  admission  predicted  a  
complicated outcome in patients with acute pancreatitis with a sensitivity 
of 100%, specificity of 80%, positive predictive value of 62% and 
negative predictive value of 100%. Scores below 10 predicted an 
uncomplicated outcome” . 
 “On admission APACHE II score was a better predictor of 
systemic complications (sensitivity 100%) than RANSON score ( 
sensitivity 66.7%). Patients with APACHE II scores >10 benefitted from 
initial ICU care with aggressive therapy aimed at disease cure and dealing 
with the complications”.     
 “Hence APACHE II Scoring can be used as a reliable tool in 
predicting the severity and prognosis than RANSON scoring in patients 
with Acute Pancreatitis”.  
 
Summary 
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SUMMARY 
 “In our study of the 33 patients, 8 (24.2%) patients suffered from 
severe acute pancreatitis of which all 8 were diagnosed with severe 
pancreatitis  by  APACHE II  score  while  only  3  of  these  8  patients  were  
diagnosed with severe pancreatitis by RANSON score”. 
 “The complications, systemic and local were seen in patients 
considered to be having severe pancreatitis by APACHE II and no 
complications were seen in patients considered to be having severe 
pancreatitis by RANSON score”.  
 “The systemic complications were multiorgan failure in 2(6.06%), 
respiratory 1(3.03%) and renal 1(3.03%). Local complications occurred 
in 2 patients (6.06%) and both had acute fluid collection”.  
 “The age range was 28-60 years (mean-44 years) and sex 
comparision was 20 (60.6 %) men and 13(39.39%) women”. 
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 “The causes of acute pancreatitis included biliary stone 14(42.4%), 
alcoholism 10(30.3%), idiopathic 9(27.2%). 6(18.1%) patients were 
chronic smokers” 
 “8(24.2%) had atleast one co-morbid disease.The common 
concomitant diseases were hypertension (37.5%), diabetes mellitus 
(25%), ischaemic heart disease (5%)”. 
 “The AUC of Apache II score was 0.717 and that of Ranson was 
0.667 , Sensitivity of Apache II was 100% and that of Ranson 66.7%, 
Specificity of Apache II was 80% and Ranson 86.7% , ppv of ApacheII 
62% and Ranson 33%, npv of Apache II 100% and Rason 96% 
respectively” .  
 “The APACHE II system is the only system which takes into 
account all the major risk factors that influence outcome from disease, 
including the acute physiological derangements as well as patient ability 
to recover which may be diminished by advancing age or chronic disease. 
The range of APACHE II score is wide providing better spread between 
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mild and severe attacks, because varying weights are assigned to 
increasingly abnormal values, rather than all or none judgements than 
RANSON scoring system”. 
 “The early diagnosis and precise scoring of disease severity are 
important goals in the initial evaluation and management of pancreatitis. 
Pancreatitis not only must be differentiated from a myriad of other 
potential diagnosis, but patients must also be stratified to identify those 
with severe disease and to guide appropriate therapy”. 
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 COMPUTED TOMOGRAPHIC PICTURES OF ACUTE 
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Figure 3: PANCREATIC PSEUDOCYST 
 
 
Figure 4: PANCREATIC OEDEMA AND NECROSIS 
 
 
Figure 5: PANCREATIC NECROSIS 
 PROFORMA 
PATIENT INFORMATION 
NAME OF PATIENT:                                        AGE/SEX: 
HOSPITAL NO:                                                 DOA: 
IP NO:                                                                 DOD: 
ADDRESS: 
CLINICAL HISTORY: 
PAIN ABDOMEN 
       Onset 
      Site & character 
      Radiation 
     Association to intake of food 
     Aggravating or relieving factor 
NAUSEA/VOMITING 
FEVER 
PAST HISTORY 
Gall stones 
ERCP 
Jaundice 
Trauma/Mumps/hyperparathyroidism 
Previous surgeries 
 Diabetes 
Hypertension 
PERSONAL HISTORY 
Alcoholism 
Drug history 
Smoking history 
ASSOCIATED DISEASES 
GIT 
CVS 
RS 
RENAL 
IMMUNOCOMPROMISED 
PHYSICAL FINDINGS ON EXAMINATION 
BUILT/NOURISHMENT/HYDRATION: 
Pallor      Icterus     Cyanosis       Lymphadenopathy     edema 
Pulse:     /min                                              Temp:      c 
BP:           mm of Hg                                   Resp rate:     /min 
GCS: 
SYSTEMIC EXAMINATION 
CVS 
RS 
 CNS 
P/A 
P/R 
PROVISIONAL DIAGNOSIS : 
INVESTIGATIONS 
 At admission & Initial 48 hrs 
S. Amylase  
Hb  
PCV  
TC  
SGOT  
S.Na  
S.K  
CREATININE  
RBS  
PO2  
BE  
ARTERIAL PH  
S.Ca  
BUN  
 OTHER INVESTIGATIONS: 
USG Abdomen 
X- ray Erect Abdomen 
RANSON SCORE: 
At a admission or diagnosis: 
Variables Value Scores 
Age over 55   
White blood cell count over 16,000/ml   
Blood glucose level over 200mg/dl   
Serum LDH>350IU/L   
SGOT>250 Sigma Frankel Units/dl   
 
Initial 48 hrs: 
Variables Value Scores 
Haematocrit decrease >10%   
BUN> 5mg/dl   
Serum calcium level <8mg/dl   
Base deficit >4meq/1   
Arterial po2<60 mm hg   
Estimated fluid sequestration >6000ml   
  APACHE 2 SCORING WORK SHEET 
 
 
OUTCOME OF APACHE II SCORING SYSTEM: 
OUT COME OF RANSON SCORING SYSTEM: 
FINAL OUTCOME OF PATIENT: 
CONCLUSION:  
 
 
 
 
 
 RANSON SCORE:79,82 
At admission or diagnosis: 
 
Initial 48hrs: 
 
Maximum Score: 11 
Score Mortality rate 
< 3 0.9% 
3 – 4 18% 
5 – 6 50% 
 > 6 90% 
 
 THE APACHE II SCORING SYSTEM 79,82 
A. Age in years 
Under 44 - 0 Points 
45-54  - 2 points 
55-64  - 3 Points 
65-745 - 5 Points 
Over 74 -  6 Points 
Point Value for Age 
B. History of severe organ insufficiency or immunocompromised? 
Yes, and non- operative or emergency post operative patient - 5 Points. 
Yes, and elective post – operative patient                                 - 2 points 
No                                                                                              - 0 points 
Point Value for History 
C. 
  
 1. Rectal Temperature (Celsius) 
· Over 40.9--------------------- 4 Points 
· 39-40.9------------------------ 3 Points 
· 38.5-38.9---------------------- 1 Points 
· 36-38.4------------------------ 0 Points 
· 34-35.9------------------------ 1 Points 
· 32-33.9------------------------ 2 Points 
· 30-31.9------------------------ 3 Points 
· Below 30 --------------------- 4 Points 
Point Value for Temperature 
2. Mean arterial pressure (mm Hg) 
· Over 159------------------- 4 Points 
· 130-159--------------------- 3 points 
· 110-129--------------------- 2 Points 
· 70-109---------------------- 0 Points 
· 50-69------------------------ 2 Points 
· Below 50 ------------------ 4 Points 
  
 3. Heart rate 
· (ventricular response) 
· Over 179--------------------- 4 Points 
· 140-179---------------------- 3 Points 
· 110-139---------------------- 2 Points 
· 70-109------------------------ 0 Points 
· 55-69------------------------- 2 Points 
· 40-54------------------------ 3 Points 
· Below 40 ------------------- 4 Points 
4. Respiratory rate (non- ventilated or ventilated) 
· Over 49-------------------------- 4 Points 
· 35-49----------------------------- 3 Points 
· 25-34----------------------------- 1 Points 
· 12-24----------------------------- 0 Points 
· 10-11----------------------------- 1 Points 
· 6-9-------------------------------- 2 Points 
· Below 6 ------------------------- 4 Points 
Point Respiratory rate 
  
 5. Arterial pH 
· Over 7.69----------------------- 4 Points 
· 7.60- 7.69----------------------- 3 Points 
· 7.50- 7.59---------------------- 1 Points 
· 7.33- 7.49 ---------------------- 0 Points 
· 7.25 – 7.32---------------------- 2 Points 
· 7.15 – 7.24 --------------------- 3 Points 
· Below 7.15 --------------------- 4 Points 
Point Value for pH 
6. Serum sodium (mMol/L) 
· Over 179 --------------- 4 Points 
· 160-179-----------------3 Points 
· 155- 159--------------- 2 Points 
· 150-154-----------------1 Points 
· 130-149--------------- 0 Points 
· 120-129 -------------- 2 Points 
· 111- 119 --------------- 3 Points 
· Below 111-------------- 4 Points 
Point value Sodium Level 
  
 7. Serum potassium (mMol/L) 
· Over 6.9 ---------------- 4 Points 
· 6.69--------------------- 3 Points 
· 5.5- 5.9 ---------------- 1 Points 
· 3.5 – 5.4 --------------- 0 Points 
· 3-3.4 ------------------- 1 Points 
· 2.5 – 2.9 ----------------2 Points 
· Below 2.5 --------------4 Points 
Point value for K Level 
8. Serum Creatinine (mg/100mL) 
· Over 3.4 & acute renal fail --------------------- 8 Points 
· 2.0- 3.4 & acute renal fail ---------------------- 6 Points 
· Over 3.4 & chronic renal fail ---------------- 4 points 
· 1.5 – 1.9 & acute renal fail-------------------- 4 Points 
· 2.0 – 3.4 and chronic ------------------- ------- 3 points 
· 1.5- 1.9 and chronic ---------------------------- 2 Points 
· 0.6 – 1.4 ------------------------------------------ 0 Points 
· Below 0.6 ---------------- ---------------------- 2 Points 
Point value for Creatinine 
  
 9..Hematocrit (%) 
· Over 59.9 ------------------------------ 4 Points 
· 50- 59.9 ---------------------------------- 2 Points 
· 46- 49.9 ---------------------------------- 1 Points 
· 30-45.9 -------------------------------- 0 Points 
· 20- 29.9 ------------------------------- 2 Points 
· Below 20 -------------------------------- 4 Points 
Point Value for Hematocrit 
10. White blood count (total/cubic mm in 1000’s) 
· Over 39 ------------------ 4 Points 
· 20-39.9 ------------------- 2 Points 
· 15- 19.9 ------------------- 1 Points 
· 30- 14.9 ------------------- 0 Points 
· 1.0 – 2.9 ------------------- 2 Points 
· Below 1.0 ---------------- 4 Points 
Point Value for WBC 
  
 11. Oxygenation 
(Use PaO2 if FiO2 <50 %, otherwise use A -a gradient ) 
A- a gradient over 499 - --------------- 4 Points 
A- a gradient 350-499 ----------------- 3 Points 
A- a gradient 200-349 ----------------- 2 Point 
A- a below 200 (if FiO2 over 49 %) or 
pO2 more than 70 (if FiO2 less than 50%) -------------- 0 Points 
pO2 = 61-70 --------------- 1 Points 
pO2 = 55-60 -------------- 3 Points 
PO2 below 55 ------------ 4 Points 
Point Value for Oxygenation 
12. GLASGOW COMA SCALE 
Point value for - Glasgow 
TOTAL OF ALL POINTS APACHE II SCORE : A+B+C 
 
 Serum Amylase level of the 33 patients in this study on admission 
Serial 
No 
Serum Amylase level 
(IU/L) 
1 260 
2 378 
3 380 
4 366 
5 260 
6 180 
7 218 
8 890 
9 714 
10 280 
11 460 
12 260 
13 190 
14 936 
15 806 
16 454 
17 743 
18 210 
19 312 
20 228 
21 217 
22 345 
23 238 
24 189 
25 1012 
26 843 
27 318 
28 452 
29 643 
30 323 
31 289 
32 218 
33 321 
 
 
  
